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SUMMARY
Approaches are described towards synthesis of 1-hydroxy-l-carba- 
cephalosporin (1), a chemically interesting nuclearly modified cephal­
osporin analogue which may possess potent antibiotic activity.
Approaches to a b’icyclic tetrahydropyridine (27), potentially 
convertible into carbacephem (1), are also discussed.
Oxygenated 1-carbacephems (95) and (97) have been prepared via a 
route employing the reaction between imines and a ketene precursor to 
give p -lactams. The 1 (X-isomer (95) exhibited weak antibiotic 
properties.
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Abbreviations and Conventions
All compounds prepared during the course of this research were 
racemic, but for clarity only one enantiomer is represented diagramat- 
ically*
The following abbreviations have been used throughout this thesis:
Penam
Cepham
A  - Cephem
A  - Cephem
DHB
OM e
M e O Ho —
Ft
fls
0
II
C H S '
G PhCH2C0NH-
V Ph0CH2C0NH-
Blt- (CH3>3 C“
BOC (ch3)3 c-o- c (o )-
DCC Dicyclohexylcarbodi imide
DME Dimethoxyethane
DNSO Dimethylsulphoxide
TFA Trifluoroacetic acid
THF Tetrahydrofuran
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Introduction
(a) Prologue
v
The history of -lactam antibiotics began in 1928 with the dis­
covery1 of penicillin by Alexander Fleming at St, Mary's Hospital,
London, Twelve years then elapsed before Florey and Chain, in Oxford,
2
isolated and purified penicillin from the crude mould extracts; it was
yet another five years before the combined results of chemical degrad—
3
ation and X-ray crystallography established the structure (1), This 
delay, from discovery to structure elucidation, was due largely to the 
extreme lability of the molecule and the unprecedented occurrence of an
azetidin-2-one unit in a natural product. The second class of ^-lactam
antibiotics to be discovered was the cephalosporin group. Giuseppe 
Brotzu, working in Sardinia, reported in 1948 that a mould, 
Cephalosporium acremonium.produced antibiotic material that showed 
activity against both Gram positive and Gram negative organisms.
Brotzu believed the isolation of the active principal to be beyond his
limited resources, and succeeded in having this work continued in Oxford
4
by Abraham, Newton and their collaborators . After extensive investig­
ations cephalosporin C (2) was isolated and its structure determined^ in 
1961. Synthetic efforts to improve the biological potency and spectrum 
of activity of these antibiotics initially concentrated on varying the 
amide side chain functionality common to both penicillins and cephalos­
porins. This situation has changed dramatically in the last decade with 
the discovery of many more fundamentally modified systems, some being 
naturally occurring and others synthetic in origin.
In 1971 the highly active 7 <X -methoxycephalosporin (3), a 
cephamycin, was isolated from a culture of Streptomyces lipmanii at the
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Eli Lilly laboratories . In 1976 three new classes of f i -lactam anti— 
biotics were reported. A group at Beechams disclosed the isolation of 
clavulanic acid (4), a potent J2 — lactamase inhibitor, from Streptomyces 
clavuligerus; this compound differed from all previously known lactam 
antibiotics in lacking an amide side chain and in possessing an oxygen 
instead of a sulphur atom at position 1. Chemists at the Fujisawa com—
0
pany in Japan reported the isolation of a monocyclic —lactam antibio­
tic, nocardicin (5), from a species of Nocardia uniforms. A team at
g
Merck Sharp and Oohm in the U.S.A. revealed their discovery of thienam— 
ycin (6) in fermentation broths of Streptomyces cattleya; almost simul­
taneously Beechams1 chemists reported^ the isolation of a related com­
pound, olivanic acid (7), from Streptomyces olivaceous. In olivanic 
acid and thienamycin the amide side chain has been replaced by a hydroxy— 
ethyl side chain, sulphur has been replaced by a methylene group at pos­
ition 1, and there is now a double bond in the fused five membered ring. 
Since the discovery of thienamycin and olivanic acid several other related 
compounds have been discovered which differ only in the stereochemistry 
at positions 6 and 8; these compounds are collectively known as the oli— 
vanic acids. Thienamycin and the olivanic acids function both as — 
lactamase inhibitors and as broad spectrum antibiotics.
The current range of naturally occurring p  -lactam antibiotics can 
thus be grouped into approximately six classes as indicated above. This 
is not so for those derived by synthesis. Chemists working in the 
laboratories of universities and pharmaceutical companies have produced 
vast numbers of p  —lactam systems with novel structures, some of which 
show pronounced biological activity. The following is a very small
selection of the more important synthetic antibiotics. In 1974,
11 . 12 
chemists at two companies, Eli Lilly and Ciba Geigy , independently
synthesised the new 3—methoxycephalosporin (8), the prototype of a
c o 2 h
( 1 0 )
c o 2 h
t 11)
group of highly active cephalsporins with an electronegative substituent 
at position 3 of the cephem skeleton. In the same year, chemists in
the laboratories of Merck Sharp and Dohm published syntheses of
13 1A
1—oxacephalothin (9) and 1-carbacephalothin (1G), both of which
showed pronounced antimicrobial activity. In 1976 Woodward described"^
the synthesis of the penem (11), a molecule which combines the fused
five membered ring of penicillin with the enamine structure of
cephalosporin. Many of the ]3-lactam compounds cited above deviate
markedly from the structural features of the original penicillins and
cephalosporins while retaining potent antibiotic activity, in some
cases even greater than that of the parent compounds. This has led to
the synthesis of a plethora of novel lactam structures in the search
for even more powerful antibiotics. In the following sections some of
the strategies which led to syntheses of such compounds will be discussed
in some detail.
(b ) Sheehan’s Synthesis of Penicillin V (1957)
Sheehan and Henery—Logan published the first rational synthesis 
of a natural penicillin, penicillin 1/, in 1957. The synthesis was 
conceived at a time when it was generally believed that the instability 
of penicillin was due to the presence of the strained four membered 
lactam ring, hence the formation of this structural feature was post­
poned for as long as possible in the synthetic sequence.
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(D)-Penicillamine (13) was condensed with t-butyl phthalimido- 
18
aldehydomalonate (12) to give the thiazolidine (14). This was a
mixture of only two racemates of the four possible stereoisomers,
one of which (the o<-isomer) corresponded to the configuration found in
natural penicillin; the other (the tf —isomer) could be epimerised into
the ot-isomer by heating in the presence of pyridine. Hydrazinolysis
of the phthalimido group of the oC-isomer, followed by acylation of
the resulting amine with phenoxyacetyl chloride, produced the phenoxy-
acetamide (15). The t-butyl ester was then cleaved with dry hydrogen
chloride to give the diacid (15), thus leaving formation of the
—lactam ring as the final step in the synthesis. This was achieved
19
using DCC, a reagent introduced by Sheehan for the formation of amide
bonds between amines and carboxylic acids.
Research groups working independently in the laboratories of two
20 21pharmaceutical companies, Roussel and Squibb , have extended
Sheehan’s methodology to the synthesis of cephalosporin. Both groups
used the lactone (17) as starting material. This compound, the
condensation product of pyruvic acid, formaldehyde, and dimethylamine,
22
was first prepared by Hannich in 1924. In the Squibb laboratories 
the dimethylamino group was displaced by trityl mercaptan to give the 
sulphide (18). Replacement of the hydroxy group by an amino group gave 
the enamine (19). Condensation with t-butyl phthalimido-aldehydomalonate 
(12) was followed by deprotection of the thiol group. Spontaneous 
intramolecular cyclisation then gave the dihydrothiazine (20) as a 
mixture of stereoisomers. The Roussel group obtained this same inter­
mediate from the lactone (17) by displacement of dimethylamine with 
thioacetic acid followed by acidic hydrolysis to the thiol (21), which 
was condensed with the amincmethylene-glycine ester (22). Hydrazinolysis 
of the intermediate (20) gave the free amino compound (23). Treatment
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of this with acid caused both ester cleavage, and also equilibration 
of the stereoisomeric mixture to give mainly the racemic threo acid (24), 
Reprotection of the amine as its trityl derivative and y^-lactam ring 
formation using DCC gave the cephem (25), The synthesis was completed
t
by deprotection of the amino group and then acylation with thienylacetyl 
chloride to give the lactone (26), The cephem carboxylic acid (27) 
could be obtained in only low yield by hydrolysis of the lactone.
This synthetic strategy has not been used to any great extent for 
the preparation of penicillin or cephalosporin analogues. The route 
suffers a lack of stereospecificity and the overall yield is very poor. 
Neither of these criticisms can be levelled against the following 
cephalosporin synthesis,
(c) Woodward’s Synthesis of Cephalosporin C (1965)
C 0 2 R
One of the outstanding features of this synthesis is the complete 
stereochemical control achieved by use of (L)-cysteine (23), masked 
and activated at the methylene position as the cyclic thiazolidine (29), 
This chiral building—block reacted stereoselectively with dimethyl 
azodicarboxylate to form compound (30); oxidative cleavage with lead 
tetraacetate gave the acetate (31) accompanied with a small amount of 
the cis epimer, Transesterification liberated the alcohol (32), This
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was transformed into the amine (35) by conversion into the mesylate (33), 
displacement with inversion with azide ion to give azide (34), and 
finally reduction with aluminium amalgam. Tri—isobutylaluminium effect­
ed smooth cyclisation of the amino-ester (35) to the y^-lactam (36).
V
This is a key intermediate, a corner stone in penam and cepham synthesis,
containing as it does the basic structural elements common to both peni—
24cillins and cephalosporins. It has been synthesised from penicillin 
itself and has been used further in the preparation of nuclearly modified 
cephalosporin analogues, as will be discussed in more detail in the next 
section. One final point to note here is that the ^-lactam ring has 
been created at a relatively early stage. To return to the synthesis 
under discussion, conjugate addition of the lactam nitrogen function 
to the dialdehyde (37) (the condensation product of malondialdehyde and 
trichloroethyl glyoxylate) gave the enolised dialdehyde (38). This 
species now contains all the elements necessary for formation of the cep­
hem skeleton. Treatment with TFA liberated the amino and mercapto groups 
and caused cyclisation to the A -cephem (39). Acylation with a protected 
(D)— p(-amino-adipic acid followed by reduction and acetylation gave cephem 
(40). The synthesis of cephalosporin C was completed by base catalysed 
isomerisation of the double bond followed by reductive removal of the 
ester protection.
This general methodology has been extended to the synthesis of
25
other -lactam antibiotics. In 1976, Baldwin described the first 
stereocontrolled total synthesis of a penicillin system. Although 
this employed a similar activation of the methylene group of (L)—cysteine,
it differed from Woodward’s cephalosporin synthesis m  that it involved
a peptide—to—^  —lactam conversion and was therefore more biogenetically
patterned. The peptide (43) was created by condensation of the 
protected (L)-cysteine (41) with (D)-isodehydrovaline methyl ester (42).
c C^CHjPh
O C H 2 Ph
P h C O N
0CH2 Ph
C02CH2Ph
( 54 ) 55
Ph C 0  N
0 C H 2 Ph
C 0 2 C H 2 Ph
Ph
ii
O C H 2 P h
c 0 2 C H 2 Ph
( 56 57
Cl
Ph C = N
i
I
C 0 2 CH2 Ph 
( 58 )
-7-
Functionalisation of the methylene group of this cysteine derivative 
was achieved by treatment with benzoyl peroxide to give the benzoate 
(44), Exposure to hydrogen chloride formed the chloride (45), which 
was then cyclised to the ^ —lactam (46), using sodium hydride to 
deprotonate the amide function. This compound now contains all the 
structural features necessary for penicillin formation. The necessary 
further transformations are removal of the acetonide protection and 
cyclisation. These were achieved by the following sequence of reactions. 
Oxidation with m—chloroperbenzoic acid formed the sulphoxide (47), which 
was rearranged to the y#-keto-sulphide (48). Formation of the epimeric 
oxiranes (49) and rearrangement then gave the epimeric aldehydes (50) 
m—Chloroperbenzoic acid oxidation produced a diastereoisomeric mixture 
of sulphoxides; thermal syn-elimination of either of these isomeric 
sulphoxides destroys the chirality at sulphur, to form a single 
sulphenic acid (51). This acid was not isolated, electrophilic attack 
on the double bond resulting in formation of the sulphoxide (52).
Reduction then gave the penicillin (53).
26A similar strategy can be seen in a stereocontrolled synthesis 
of nocardicin A carried out in the laboratories of Eli Lilly and published 
in 1978. The synthesis parallels that of Baldwin with a protected 
(D)-isodehydrovaline (42) being replaced by a protected (D)-£-hydroxy- 
phenylglycine (54). DCC-Mediated coupling of the amine (54) with the 
protected (L)-cysteine (41) furnished the peptide (55). Sequential 
treatment with benzoyl peroxide, hydrogen chloride, and sodium hydride 
formed the ^-lactam (56), obtained as an epimeric mixture due to 
epimerisation ol. to the ester group; recrystallisaticn under equilibrat­
ing conditions gave the pure isomer (56), Treatment of this with aqueous 
mercuric acetate gave the oxazolidone (57) which underwent cleavage 
with phosphorous pentachloride to produce the chloro derivative (58).
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Reductive dechlorination followed by hydrolysis afforded the protected
3—aminonocardicinic acid (3—ANA) (59). The synthesis of nocardicin A
9 7
was completed by acylation with the glyoxylic acid (60) as outlined 
in Scheme 1.
(d) The Conversion of Penicillins into Cephalosporins
6—Aminopenicillanic acid (6—APA) is produced in very large quantities
by fermentation and is therefore quite inexpensive. This is not true
of 7—aminocephalosporanic acid (7-ACA), so considerable effort has been
expended in the search for methods of conversion of penicillins into
28 29
cephalosporins. Success was first achieved by Fibrin ’ and co- 
workers at the Eli Lilly laboratories in 1963. Oxidation of the 
penicillin ester (61) with sodium metaperiodate gave the -sulphoxide 
(62). When heated in acetic anhydride this was converted into a 2:1 
mixture of penam (63) and cepham (64). Cepham (64), on treatment with 
triethylamine, eliminated acetic acid to form 3/-deacetoxycephalosporin 
(65). Alternatively, the penicillin sulphoxide (62) could be converted 
directly into the cephalosporin (65) by heating in xylene containing a 
catalytic amount of TsOH. The mechanism of this reaction involves 
displacement of a sulphoxide—sulphenic acid equilibrium by formation 
of an episulphonium ion from the sulphenic acid under the reaction 
conditions. The various products observed can be explained by alter­
native fates of the episulphonium ion (Scheme 2). This ring expansion 
reaction of penicillin sulphoxides is new the basis of a commercial
production^ of the orally active cephalexin (66) from a penicillin.
31In 1972 Woodward described the synthesis of a nuclearly modified 
cephalosporin (74) from a penicillin, which involved a new method for 
the construction of a bicyclic skeleton from a monocyclic j i  — lactam.
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Curtius degradation of a penicillin, followed by treatment of the result­
ing isocyanate with 2,2,2,-trichloroethanol gave the penicillin derivative 
(67). Reductive removal of the trichloroethyl group with zinc in the 
presence of water led to the aldehyde (68). Reduction to the alcohol was 
followed by reprotection as the 2,2,2,-trichloroethyl carbonate (69).
This monocyclic y£—lactam condensed with j:—butyl glyoxylate to produce an 
epimeric mixture of hydroxyamides (70), which were converted into the 
corresponding chlorides (71) using thionyl chloride. Reaction of the 
chlorides with triphenylphosphine in the presence of base gave the stable 
phosphorane (72). The sequence (69) to (72) permits a new procedure for 
construction of a bicyclic skeleton from a monocyclic ^  -lactam. Two 
new carbon atoms are introduced, one of which will become the carboxyl 
group common to both penicillins and cephalosporins and the other is part 
of a phosphonium ylide which will be used in a Uittig reaction to complete 
the bicyclic structure. This general method of annelating -lactams.-.has 
been used in many laboratories for the synthesis of analogues of 
penicillin and cephalosporin; some examples of these will be seen in 
the following sections. The synthesis was completed by deprotection 
of the alcohol and oxidation to the corresponding aldehyde, which under­
went spontaneous cyclisation to the protected cephem (73). Removal of 
the ester protection gave the free acid (73), which 'doodward called a 
"cephalocillin" because it had features common to both cephalosporin 
(an enamine group) and penicillin (a gem—dimethyl group).
In the same year, the previously discussed intermediate (36)
24
was synthesised from penicillin by Heusler . The synthesis proceeded 
via the aldehyde (68c) which exists as the hemiaminal (75). Photo­
induced oxidation with lead tetraacetate gave the N-formyl -lactam (76). 
Thermal elimination of acetic acid followed by selective cleavage of the 
formyl group with aqueous ammonia produced the thio—alkene (77).
X
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Liberation of the free amine by treatment with TFA was accompanied by
intramolecular cyclisation to give the thiazolidine (78), and thence
the key intermediate (36). This represents a formal synthesis of a
cephalosporin from a penicillin. However, this is not commercially
viable due to the large number of steps involved. Its importance lies
in the variety of nuclearly modified cephalosporin antibiotics which
have been prepared from the intermediate (36). A comprehensive account
of these analogues is outwith the scope of this review, but one series
32
of compounds synthesised from this building block which possess 
interesting antimicrobial activity is outlined below.
The phosphorane (79) was prepared from (36) by application of the 
glyoxylate condensation sequence detailed above. idittig reaction with 
a series of cx-keto aldehydes gave the condensation products (80) as 
mixtures of geometric isomers. These could be separated chromatographi— 
cally and additional (Z)—isomer obtained by photochemical isomerisation 
of the undesired ( E )—isomer. TFA-Mediated cleavage of the _t-B0C
group was followed by intramolecular cyclisation and dehydration; the 
t-butyl ester was also cleaved, although more slowly, and the ultimate 
product was the amino acid (81). Acylation gave the cephalosporin 
analogues (82), which exhibited good antibacterial activity against 
both normal and penicillin resistant strains of S. aureus and other 
microorganisms.
The abnormal Pummerer ring expansion is an important commercial
route to a number of cephalosporins. The transformation of penicillins
into cephalosporins carried out in liloodward’s laboratories are not
commercially viable but they do allow the preparation of many different
33
analogues. The following method, reported by Kukolja in 1976, offers 
a penicillin to cephalosporin conversion which is both commercially 
feasible and can potentially lead to a wide range of cephalosporin
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analogues. The exomethylene cepham (86) was synthesised from the 
penicillin sulphoxide (83) by the following route. Oxidation with 
N—chlorosuccinimide, or another source of positive halogen, gave the 
sulphinyl chloride (84), which cyclised to the exomethylene cepham 
sulphoxide (85) on treatment with Lewis acid. The sulphoxide function 
was then reduced to give the cepham (86). This constitutes a very 
short, high yielding sequence of reactions which uses relatively 
inexpensive reagents. The exomethylene cepham (86) is a versatile 
intermediate for the synthesis'^ of a wide range of cephalosporins, as 
outlined in Scheme 3.
(e) The Merck Synthesis (1973)
The synthetic approach adopted by chemists in the laboratories 
of Merck Sharp and Dohm involves formation of ^-lactams by cycloaddition
of imines with ketenes or ketene equivalents. This reaction was first
35observed by Staudinger in 1907 and has been extensively studied by
7 c 3 7 - i -
Bose . Indeed, Bose synthesised methyl (-)-6-epipenicillanate (90) 
via such a cycloaddition reaction. The thiazoline (87), prepared 
from W-formyl (1)-penicillamine, was treated with azidoacetyl chloride 
and triethylamine to give the trans —lactam (88) in low yield. 
Surprisingly, the epimeric ^-lactam (89), another possible product
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of this reaction, does not appear to be formed. The isolated
^ —lactam (88) was reduced to the corresponding amine and then acylated
to give the racemic penicillin derivative (90). This synthesis does
not produce an active antibiotic and also suffers from a very low yield
of the cyclisation product (88).
The Merck group, on the other hand, achieved the synthesis of
38
a biologically active cephalosporin in far superior yield. The 
triazine (91), prepared from benzylamine and formaldehyde, was heated 
with diethylphosphite to give diethyl N—benzylaminomethylphosphonate, 
isolated as its hydrochloride salt (92). Hydrogenolysis and neutrali­
sation furnished diethyl aminomethylphosphonate (93). The
Schiffs base from amine (93) and benzaldehyde was acylated by sequential 
treatment with phenyl lithium and benzyl chloroformate. Deprotection 
then gave the key synthon (94), which was converted into the thioform- 
amide (95) by treatment with ethyl thionoformate. Condensation with
1—chloro—3—acetoxy—2—propanone produced the tniazine (96). Cycloaddit­
ion using azidoacetyl chlGride and triethylamine yielded the 7oC-azido- 
cephem (97). Epimerisation at C-7 was achieved by reduction to the 
amine, formation of the Schiffs base with £-nitrobenzaldehyde,
deprotonation of the Schiffs base with phenyl lithium, and kinetically
39
controlled quenching of the resulting anion, to give a 55:45 ratio 
of the 7y#:7<X isomers. Liberation of the amine and separation of the 
cis—isomer by chromatography afforded the 7—aminocephem (98). Acylation 
with thienylacetyl chloride, followed by hydrogenolysis produced race­
mic cephalothin (99), which possessed half the activity of the
naturally derived compound. The kinetically controlled epimerisation
39
described above has been applied bv the Merck group to a synthesis 
of penicillin, in a synthesis which closely parallels thau of Bose 
but which produces a biologically active species.
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The Merck synthesis of cephalosporin is convergent and, as such, 
is ideally suited to the preparation of nuclearly modified analogues of 
cephalosporin. Before 1973 it was generally believed that the sulphur 
atom in cephalosporin was necessary for antimicrobial activity. To
v
test this hypothesis, the Merck group synthesised analogues of cephalo­
sporin in which the sulphur atom is replaced by an oxygen atom or a 
methylene group. (^)-l-Oxacephalo.thin; was. prepared*^ as follows. The 
thioformimidate (100), obtained by treating thioformamide (95) with 
methyl iodide and potassium carbonate, reacted with azidoacetyl 
chloride and triethylamine to give the trans-^-lactam (101). Non— 
stereospecific conversion to the chlorides (102) was achieved using 
chlorine gas. Silver (i) catalysed displacement with l-hydroxy-3- 
acetoxypropanone gave lactam (103) as a cis-trans mixture. Emmons
cyclisation then produced, after chromatography, the cis-oxacephem 
(104). Hydrogenolytic ester deprotection was accompanied by concomitant 
reduction of the azide to the amine. Acylation of the resulting amino 
acid with thienylacetyl chloride gave (1)—1—oxacephalothin (105). This 
possessed antibacterial activity comparable with racemic cephalothin; 
against some organisms the oxygen analogue was actually more potent than 
the parent compound. This demonstrates that sulphur is not essential 
for activity, but does not rule out the possibility that oxygen is 
replacing sulphur in binding to an electrophilic site on the enzyme with 
which these molecules interact. However, the synthetic route was 
adapted^ to allow the preparation of (-)—1—carbacephalothin (106)
(Scheme 4). This, too, was found to retain most of the activity of 
the parent compound, thereby proving that the presence of sulphur is 
not required for biological activity. Interestingly, in the first two 
examples the cycloaddition reaction gave the trans—oriented ^ —lactams 
(97) and (101) but in the carbacephalothin synthesis only the
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cis-substituted product was detected.
A very similar sequence of reactions was used for the first total
42
synthesis of 3—ANA (111) reported in 1976 from the Fujisawa laboratories. 
The protected (D)-j>-hydroxyphenylglycine (107) was converted into the 
thioimidate (108). -Lactam formation using phthalimidoacetyl chloride 
resulted in the formation of lactam (109), together with the other 
possible trans-isomer. Desulphurisation with Raney nickel followed by 
hydrogenolysis of the benzyl ether gave a diastereoisomeric mixture of 
reaction products, from which the desired isomer (110) could be obtained 
by chromatography. The synthesis of 3-ANA (111) was completed by 
halogenolytic fission of the methyl ester and liberation of the amino 
group.
The achievement of the Merck chemists in synthesising nuclearly 
modified cephalosporins which were potent antibiotics has stimulated 
many research groups to seek other nuclearly modified analogues with 
even greater antimicrobial activity. The cycloaddition of imines with 
ketenes has been used extensively in this search and one particularly 
noteworthy variation was developed in the laboratories of Smith Kline 
and French (SKF). This is discussed in detail in the following section.
(f) Smith Kline and French Route (1977)
-15-
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The innovation introduced by chemists at SKF was the use of
2.4—dimethoxybenzylamine as the amine component for imine formation.
The dimethoxybenzyl group could then be removed from the -lactam thus 
produced to give a nitrogen-unsubstituted monocyclic azetidinone. This 
sequence is effectively equivalent to using ammonia in the formation of 
a monocyclic y^-lactam. The lactam (112) was prepared by addition 
of the mixed anhydride of azidoacetic acid and TFA to the imine from
2.4-dimethoxybenzylamine and methyl glyoxylate; only the cis-isomer 
was obtained. Reduction of the azide followed by acylation gave the
amide (113). The dimethoxybenzyl group was then oxidatively removed
43 / \
with buffered potassium persulphate to give the free lactam (114).
43—45
This species is a versatile intermediate for the synthesis of
nuclearly modified penicillin and cephalosporin analogues, some of
which are shown in Scheme 5.
Removal of the dimethoxybenzyl group leaves a ^-lactam capable
of undergoing the Woodward glyoxylate condensation sequence. Such a 
46strategy can be seen in the synthesis of the benzo—fused carbocyclic 
-lactam (118). Oxidative cleavage of the dimethoxybenzyl group of 
lactam (115), followed by reduction and acylation afforded the amide
(116). The glyoxylate condensation sequence then furnished the phos- 
phorane (117). Aldehyde deprotection was followed by spontaneous 
cyclisation. Hydrogenolysis to the free acid (118) gave a compound 
inactive against a range of organisms.
47Recently the same group reported the synthesis of a very inter­
esting compound (127). Reduction of the ester (112) to the correspond­
ing aliohol with NaBH^, followed by oxidation, gave the aldehyde (119). 
Condensation with nitromethane afforded nitro—alchol (120) which was 
converted into the nitroethylazetidinone (121) by dehydration and 
reduction of the resulting olefin (again using NaBH^). The
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nitroethylazetidinone (121) was transformed by a modified Nef reaction
into the acetal (122). Oxidative removal of the dimethoxybenzyl group
and condensation with benzyl glyoxylate furnished an epimeric mixture
of adducts, which could be separated chromatographically into epimers
(124) and (125). On treatment with TsOH, epimer (124) cyclised to
the single stereoisomer (126), the structure of which was confirmed by
X-ray analysis. This synthesis was completed by hydrogenolysis of the
benzyl ester with concomitant reduction of the azide group. Acylation
then gave the cepham analogue (127). That this proved to be a potent
antibiotic is surprising because (i) compound (127) lacks the enamine
48
group considered necessary for activity in a 4:6 fused y^-lactam and 
(ii) the 4 j3 -carboxyl group in (127) is of the opposite configuration 
to that of the 3 oC -carboxyl group found in penicillin. The epimeric 
compound (128) prepared from isomer (125) did not possess any significant 
antibacterial properties.
(g) The Hoechst Approach (1974)
49 . .
The discovery by Graf that N-chlorosulphonyl isocyanate (CSI)
reacts with olefins to give ^-lactams, from which the chlorosulphonyl
group can readily be removed, stimulated chemists at Hoechst in West
Germany to prepare derivatives of the -lactam antibiotics via this
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cycloaddition reaction. After much experimentation the following 
synthesis of a cephem was achieved"*^. The acetoxyazetidinone (129) 
was prepared by reaction of v/inyl acetate with CSI, followed by hydro­
lysis of the chlorosulphonyl group. The dimeric compound (130) reacted 
with lactam (129) in tine presence of base to give a product (131)
corresponding to the displacement of acetate by mercaptoacetone.
Lactam (131) was then converted into phosphorane (132) by Woodward's
method. Pyrolysis of phosphorane (132) gave a mixture of the
2 3A  -cephem (133) and the A  -cephem (134), converted into pure isomer
(134) on treatment with base. Attempts to functionalise the C-7
position of cephem (134) via deprotonation failed due to preferential
deprotonation in the six membered ring. This latter process could
be blocked by acylation of cephem (134) to give diester (135).
Deprotonation then occurred at the C-7 position and reaction of this
anion with TsN^ gave the trans-azide (136). Reduction, hydrolysis
and decarboxylation, and finally re-esterification gave the amine (137)..
The transformations necessary for the conversion of amine (137) into an
active cephalosporin have been reported earlier. The trans-amine can
be isomerised into its cis—isomer via deprotonation—kinetic reprotonat-
38 2
ion of its Schiffs base. A deacetoxy- A  —cephem has been converted
3
into an acetoxy— A  -cephem via bromination, displacement with acetate,
2
and oxidation—reduction of the sulphur atom to isomerise the A  —double
■ .51bond .
This synthesis'was abandoned because the many steps involved rendered
it commercially impractical. However, the above transformations
demonstrate that this approach does lend itself to the preparation of
bicyclic y^-lactams. In particular, preparation of the acetoxy
j3 -lactam (129) and nucleophilic displacement of the acetate group were
52significant as can be seen in the following synthesis of clavulanic
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acid. The Beechams group used as their starting material the thiomethyl
53
—lactam (138), first prepared by the Hoechst team . Alkylation 
with dimethyl 2-bromo-3-oxoglutarate (139) gave the ^-ketodiester (140), 
which on treatment with a slight excess of chlorine afforded the chloro 
compound (141). Cyclisation to the bicyclic compound (142), isolated 
as a single racemic isomer, was achieved with anhydrous potassium 
carbonate in dry DMF. Photolysis of a benzene solution of (142) 
resulted in isomerisation about the double bond to an inseparable mix­
ture of (142) and (143). Reduction of the mixture with Bu^AlH gave 
a mixture of the corresponding allylic alchols, from which the desired 
methyl (it)—clavulanate (144) was isolated. This represents a formal
total synthesis of (it)-clavulanic acid, methyl clavulanate being hydro-
54
lysable to clavulanic acid •
55
The first total synthesis of thienamycin (5) also employed C5I 
cycloaddition with olefins as the initial step. p  -Lactam (145) was 
formed by reaction of CSI with 1-acetoxybutadiene, followed by hydrolysis 
of the chlorosulphonyl group. Hydrogenation and ester exchange gave 
the hydroxyalkyl azetidinone (146) which was protected as the correspond­
ing acetonide (147). Treatment with lithium diisopropylamide and 
acetaldehyde at -78°C then produced the trans-alkylated product (148), 
epimeric at the carbinol carbon. The alcohol was protected as its 
£-nitrobenzyl carbonate and the acetonide cleaved to give alcohol (149). 
This was oxidised to the aldehyde (150), which was converted into the 
dithioacetal (151). Sequential treatment with bromine and triethylamine 
caused elimination of one of the protected cysteamine groups, forming 
thioenol ether (152). Condensation with bis(js-nitrobenzyl) oxomalonate 
afforded hydroxy diester (153) which was converted into chloride (154). 
Reduction with tri-n-butyl phosphite to diester (155) followed by 
bromine—induced cyclisation gave the bicyclic compound (156).
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Dehydrobromination was followed by selective deprotection of one 
£-nitrobenzyl ester with one equivalent each of collidine and methyl 
iodide. The resulting malonate half-acid underwent decarboxylation on 
acidic work up, affording a diastereoisomeric mixture of monoesters 
(157) from which the desired (8R)-isomer could be obtained by chromato­
graphy. Base catalysed double bond isomerisation produced a separable 
mixture of alkene isomer (158) and starting material. Hydrogenolysis 
of the isolated protected thienamycin (158) gave (1)—thienamycin, poss­
essing half the antibacterial activity of the naturally occurring 
antibiotic.
(h) The Lowe Synthesis (1971)
<  >
56In 1965, Corey reported formation of the ^-lactam (160) upon
photolysis of the diazoamide (159). Lowe, at Oxford, has extended
57 . .this reaction to the synthesis of analogues of the -lactam antibio­
tics. (D)-Pipecolic acid benzyl ester (161) was condensed with the 
t-butyl half—ester of malonic acid using DCC and producing the amide 
(162). The requisite o(-diazoamide (163) was generated by diazo—group 
transfer from TsN^ in the presence of triethylamine. Photolysis of 
this diazo compound gave a mixture of the cis— and trans— 0 —lactams 
(164), with trans-stereochemistry in the six-membered ring. The cis-
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-lactam was isolated chromatographically and the free acid (165) liber­
ated. Curtius rearrangement of the corresponding acid azide (167) would 
then enable transformation of the C—7 carboxyl group into the required 
amino/amido group. However, attempts to convert the acid (165) into the 
acid azide (169) via the acid chloride or mixed anhydride caused epimeris- 
ation at C-7. The azide was therefore obtained by coupling of the acid 
with t-butyl carbazate to give the hydrazide (166) and thence the azide 
(167). The isocyanate resulting from Curtius rearrangement was not iso­
lated, but was transformed into the t-butyl urethane (168) by the addit­
ion of ^t-butanol to the refluxing benzene solution. Deprotection of the 
urethane and acylation of the resulting amine with phenylacetyl chloride
afforded amide (169). Catalytic hydrogenolysis then gave the inactive
58
nuclearly modified analogue (170).
This compound’s lack of antimicrobial activity is not surprising in
3
view of the absence of a A  -double bond in the six-membered ring. The
59
synthesis was therefore adapted , replacing the starting pipecolyl ester 
with a thiamorpholine (Scheme 6). The sulphur atom in the thiamorpholine 
enables the late introduction of unsaturation into the six-membered ring. 
In this synthesis it proved extremely difficult to obtain a product with 
the cis-orientation of the y(3-lactam substituents. To overcome this, a 
methyl group was introduced at C—7, alkylation occurring from the less 
hindered o^-face of the molecule. The isocephem (171) ultimately obtain­
ed was also inactive. Since the isocephem obtained by the 3KF group 
(Scheme 5) is a very potent antibiotic, it can be deduced that the inact­
ivity of (171) is due to the presence of the 7-<X -methyl substituent.
Very recently the Beechams research group^ have used an ot-diazo 
amide for the synthesis of an olivanic acid derivative (Scheme 7). The 
resulting product was racemic, possessing half the antimicrobial activity 
of the naturally occurring compound.
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(i) Recent Developments
Woodward's Penem Synthesis
\
The y£-lactam ring in penicillin is more reactive than simple
monocyclic azetidinones towards nucleophilic cleavage. This can be
explained in terms of the fused five-membered ring preventing the
nitrogen substituents from adopting a planar conformation and thereby
reducing the delocalisation of the nitrogen lone pair into the adjacent
carbonyl T f-orbital. In cephalosporin, the nitrogen substituents
can adopt a planar conformation; however the p -lactam in cephalosporin
is also chemically more reactive than a monocyclic ^-lactam. The
explanation for the lability of the amide bond in cephalosporin is that
the nitrogen lone pair is delocalised into the /^system of the adjacent 
3
A  —double bond. This reduces the delocalisation into the adjacent 
carbonyl fT-system, rendering the carbonyl group more susceptible to 
nucleophilic attack. Woodward envisaged that a compound which incor­
porated both of these activating features would be very reactive towards 
nucleophiles and might therefore be an extremely potent antibiotic.
In 1976 he reported the synthesis of such a compound, the penem (11), 
a -lactam possessing a fused five-membered ring containing an enamine 
group. This was indeed a very labile system and several approaches to 
it met with failure. After extensive investigation the following high 
yield synthesis^ of (11) was developed.
The penicillin sulphoxide (172) was heated in acetic anhydride 
and trimethyl phosphite to give the thioacetate (173). Double bond 
isomerisation followed by ozonolysis produced the oxalyl derivative (174). 
Diborane reduction afforded the hemiaminal (175), a species obtained 
in earlier investigations by methanolysis of (174) to the nitrogen
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unsubstituted ^ —lactam followed by condensation with £— nitrobenzyl 
glyoxylate. Continuation of the sequence gave the phosphorane (176)#
The synthesis was completed by Uittig condensation to give ester (177) 
followed by hydrogenolysis. Penem (11) was an antimicrobial agent but 
its potency was reduced by its extreme lability. Nevertheless the 
synthesis of this important compound, by a very short sequence of react­
ions giving optically pure material, is an outstanding achievement in 
the field of ^ —lactam synthesis. It is also noteworthy that the 
synthesis was accomplished by well established transformations, most 
of which have been discussed in the previous sections.
Merck C-3 to N Cyclisation
62 +
In 1978 the Merck group published a synthesis of (_)-l-oxabisnor—
penicillin G (Scheme 8) involving insertion of a C-3 carbene into the l\l-H
bond, the carbene being generated by Rh(0Ac)2 catalysed decomposition
of the appropriate diazo compound. This novel cyclisation was then
63
extended to the synthesis of the 1-carbapen—2—em system found in
thienamycin (Scheme 9). In this example the ring closure proceeded in
near quantitative yield to give a single isomer. Very recently the
64
process research team at Merck published a total synthesis of thiena­
mycin based on the above reactions.
Diethyl 1,3-acetonedicarboxylate (178) was condensed with benzyl- 
amine to give the enamine (179). Acylation with ketene gave, cleanly, 
the C—acylated product (180). This exhibited a high degree of rigidity 
due to the strong hydrogen bonding between the nitrogen proton and the 
carbonyl oxygen. Sodium cyanoborohydride reduction of enarr.ine (180) 
proceeded stereoselectively, probably via a boron chelate, to the all 
cis reduction product (181). Acid catalysed ester hydrolysis was
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accompanied by lactonisation to give, after h.ydrogenolysis, the cry­
stalline lactone (182), Lactonisation introduces a necessary discrimi­
nation between the two carboxyl groups; treatment with benzyl alcohol
afforded an equilibrium mixture of lactone (182) and ester (183), from 
/ \ %which lactone (182) could be removed and recycled. The amino acid (183)
was cyclised to the p> -lactam (184) with DCC. Protection of the amide
nitrogen as its t-butyldimethylsilyl derivative and hydrogenolysis gave
the carboxylic acid (185). Chain elongation to -keto ester (186)
was achieved by modification of a published^ procedure. After removal
of the protecting group from the p  -lactam nitrogen, the configuration
66of the hydroxyethyl side chain was inverted by a "Mitsunobu procedure” 
(Scheme 10). The inverted alcohol (187) was treated with TsN^ and 
triethylamine to give the diazo compound (188) and thence the bicyclic 
f t -ketoester (189). Transformation via the enol phosphate (190) into 
the protected thienamycin (191) andchydrogenolysis then gave (.1.) 
thienamycin (6). The overall yield of this synthesis is greater than 
10% and, since it employs only simple reagents, the Merck group believes 
that it will form the basis of an industrial preparation of thienamycin.
Stereocontrolled Synthesis of 7£X -Methoxy-l-oxacephalosporin
In 1979 a research group at the Shicnogi Company in Japan reported 
that the 7 (X-methoxy-l-oxacephalosporin (203) possessed potent antibiotic 
activity against a wide range of Gram-negative organisms. These includ­
ed p  —lactamase producing resistant strains, pathogenic anaerobic
bacteria and Pseudomonas species, which were not susceptible to other
67 68
cephalosporins . In 1980 the same group published the following
commercially feasible, stereocontrolled, synthesis of the antibiotic
(203) from penicillin.
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This synthesis is a development of the group's original preparat—
69
ion in that all the carbon atoms of the penicillin starting material 
are retained in the product and that expensive reagents have been replac­
ed. Penicillin G diphenylmethyl ester (192) was converted into the 
6—epipenicillin sulphoxide (193) by base catalysed isomerisation, 
followed by oxidation of sulphur. The epi-oxazoline (194), obtained 
by heating sulphoxide (193) in the presence of triphenylphosphine, was 
functionalised at the allylic methyl group by reaction with chlorine to 
give the dichloride (195). In this reaction, the allylic chloride 
arises by an "ene" reaction of the alkene (194) with chlorine gas. 
Treatment of the dichloride with aqueous sodium bicarbonate furnished 
the epi-oxazoline (196). Direct conversion of chloride (196) into 
alcohol (199) failed, but the required alcohol was obtained by conver­
sion of the chloride into the nitrate (198) via the iodide (197). 
Reduction of the nitrate with zinc and acetic acid then gave the desired 
alcohol (199), which underwent stereospecific BF^-catalysed cyclisation 
to the exomethylene oxacepham (200). Addition of chlorine to the 
exomethylene double bond, followed by base-induced elimination of HC1 
gave the 7-epi-l-oxacephem (201). This was converted into the 7oC.-
methoxy compound (202) by sequential treatment with t-butyl hypochlorite
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and lithium methoxide, a reaction originally developed for the chemi­
cal preparation of cephamycins from cephalosporins. The synthesis was 
completed by chloride displacement with sodium 1-methyl-l-jH-tetrazole—
5-thiolate, phosphor'”"'js pentachloride mediated deacylation to the 7- 
amino compound, reacylation, and finally removal of the ester protect­
ing group.
r
■NH
S Me
( 1 3 8 )
0
S '
— N
( 2 0 6 )
5 Me
( 2  0 4 )
( 2 0 7 )
0
.Cl
( 2 0 5)
Ph3C NH »SMe Ph^C N h j
( a )
NH ( b ) ■>
iSMe Ph3C NH
0 d )
a )
C02B u ' i
( e )
C O2 Bu
Ph .C N H
OH
( f ) OH
a ) L i N ( Si M e 3 ) 2 ( b ) Br C H2 C O2 B i/
c ) C I 2 ( d ) Na N
(2 0 8 )
3 ( e ) C H = C C 0 CH 3 (f) a
S C H E M E  11
Cl
( 2 0 9 ) ( 2 1 0 )
-25-
Fused -Lactams by 1,3-Dipolar Cycloadditions
71
Very recently, a research group at Beechams has reported the 
synthesis of biologically interesting compounds via intramolecular dipo­
lar cycloaddition between an azido group and an alkyne. The synthesis 
of the tricyclic 1-azapenam analogue (207) employed the thiomethyl 
f3 -lactam (138) as starting material. Treatment with lithium hexameth— 
yldisilazane and 3-bromoprop-l-yne gave the acetylenic ^-lactam (204), 
which was converted into the chloride (205) by treatment with chlorine. 
Reaction with sodium azide afforded the tricyclic compound (207), 
presumably via the intermediate azide (206); this reaction was carried 
out at high dilution in order to minimise intermolecular interactions.
The tricyclic j3  -lactam proved to be a j3  -lactamase inhibitor with a 
potency comparable to that of clavulanic acid. A similar sequence of 
reactions (Scheme 11) produced a highly active tricyclic 1-azacephalos- 
porin analogue (208), The starting material here was a chiral y#-lactam, 
obtained by degradation of a suitably protected penicillin.
Novel Approaches to the Nocardicins
The nocardicin skeleton, being monocyclic, allows greater varia­
tion in synthetic approach than do the more usually encountered fused 
bicyclic ^-lactam structures. liiasserman has been particularly active 
in the development of novel methods in this area, as the following two
syntheses of nocardicin illustrate.
72In one synthesis, described in 1978, the y^-lactam ring is 
created by acylation of the aminomalonate (209) with 3—chloropropionyl 
chloride to give the ^-chloroamide (210), which cyclised to the 
-lactam (211) on treatment with sodium hydride. This is a more
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general example of the mode of ^-lactam ring formation employed by 
25
Baldwin in a stereocontrolled synthesis of penicillin. The 3—azido 
derivative (212) was obtained by sequential treatment of lactam (211) 
with lithium diisopropylamide and TsN^. Saponification and decarboxy— 
lation gave the mono—acid, which was then protected as its benzyl ester
(213). This ester was obtained as a mixture of diastereoisomers which 
could be separated chromatographically and the undesired isomer equilib­
rated with base and thus recycled. Hydrogenation of the desired isomer 
gave (i)-3-ANA (111).
73A second synthesis proceeds via an azetidine with potential for 
oxidation to an azetidin-2-one. The azetidine (215) was prepared from 
t-butyl 2,4-dibromobutyrate and the £-hydroxyphenylglycine derivative
(214). Cleavage of the ester with TFA gave the acid (216), which was 
converted directly into the decarboxylated iminium salt (217), by 
sequential treatment with oxalyl chloride and perchloric acid. Oxidat­
ion of the salt (217) with m-chloroperbenzoic acid and pyridine gave the 
azetidinone (218). This was transformed into the malonate derivative 
(219) and thence to (*)-3-ANA.
Synthesis via the Ugi Reaction
The Ugi reaction"^ is a four-component condensation involving 
carbonyl, amino, carboxyl and isonitrile groups which results in the 
formation of an o(—acylamino amide (Scheme 12). Creation of two amide
moieties provides a strong driving force for the reaction. In 1962
75 .Ugi applied this condensation to the synthesis of a penicillin
derivative (Scheme 13). This approach was not pursued further because
it produced the undesired stereochemistry at C-3.
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76In 1977 Just unsuccessfully attempted to use the Ugi condensation 
for the synthesis of a 1-oxacephalosporin. The main features of the 
proposed synthesis are outlined in Scheme 14. The stereochemistry
introduced at C-4 is irrelevant since it will be destroyed in the sub—
' 3
sequent formation of the A  -double bond. The thiazolidine mesylate 
77
(222), prepared from mannitol diacetonide (221) (Scheme 15), was 
employed as starting material. Condensation with the 2—phthalimido—3— 
hydroxy-acrylate ester (223) afforded the enol ether (224). Hercury- 
catalysed hydrolysis of the thiazolidine to aldehyde (225), followed 
by reaction with ammonia furnished the monocyclic imine (226). Attempts 
to hydrolyse the methyl ester in (226a) caused decomposition of the ring 
system. To circumvent this problem the benzyl ester (226b) was pre­
pared. This again did not give the desired acid but instead gave a
product (227) of decarboxylation. An additional complication in these 
reactions was the reactivity of imine (226)fcwards nucleophiles, which 
resulted in formation of the ring—opened compounds (228). The nucleo­
phile could be an alcohol or water, water being the solvent normally 
used in the Ugi condensation. Since it appeared that the acid (220) 
could not be prepared from the ester (226), the synthesis was 
abandoned.
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Ugi took up the challenge and in 1979 published a successful 
application of a four—component condensation in Just's synthetic scheme. 
Concentrating attention on the natural cephalosporin system, rather 
than a 1-oxacephalosporin, the thiazoline (229) was prepared using the 
methods developed by Just. Ugi also commented on the instability of 
this compound but, with careful control of the reaction conditions, 
was able to cleave the methyl ester with lithium iodide and pyridine in 
DHF. The resulting acid (230) was too unstable for purification and 
was therefore condensed directly with t-butyl isonitrile to give the
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cepham (231), Here the usual solvent, water, could not be employed 
but a CH2Cl2“Et20 mixture proved to be effective. The stereochemistry 
at C-4 was /3 , as expected, and the stereochemistry across the /5-lac- 
tam ring was trans. The cepham (231) contains sufficient functionality 
for transformation into a biologically active cephalosporin. Hopefully, 
one of the two research groups will complete the synthesis. However, 
the difficulties inherent in this approach may render it of more esoteric 
interest than of practical importance.
(j) Epilogue
Although work continues on the development of new approaches to
the synthesis of /3-lactam ring systems, the major synthetic effort
lies in the preparation of analogues of the known /3-lactam antibiotics
using the above routes. Recently, considerable effort has also been
expended on interchanging various structural features of the different
classes of /3-lactam antibiotics, for example, replacement of the
6-amido side chain in penicillin by the hydroxyethyl side chain of the
79
olivanic acids. The synthetic route employed in this transformation 
is outlined in Scheme 16. The isomers (232a)-(232d) were separated by 
chromatography and the free acids obtained by hydrogenolysis. It was 
found that the trans-isomers were of equivalent activity but were less 
active than the cis-isomers which also possessed equal activity. All 
of the isomers were, however, considerably less active than penicillin.
Another example of the hybridisation of different classes of /3 -lactam
8 0
antibiotics is the penem (233), prepared by a standard sequence of 
reactions (Scheme 17). This compound, being unsubstituted at C-6, 
is reminiscent of clavulanic acid, and it carries a cysteamine side 
chain at C-2 like the olivanic acids. The penem nucleus itself
-29.
is a hybrid of penicillin and cephalosporin, hence structure (233) 
represents a hybrid of four classes of ^-lactam antibiotics. In this 
case the novel substitution pattern resulted in improved antibiotic 
properties.
This is but a short survey of the more important syntheses of
p  -lactam antibiotics. For an extensive account of synthesis in this
. 81
field the reader is directed to an excellent comprehensive review 
which appeared during the preparation of this account.
-38-
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Results and Discussion
The research described herein has been directed towards synthesis 
of the nuclearly modified cephalosporin (1). The motivations for 
initiating such an investigation were manifold. The target compound 
may be superior or complementary to the parent antibiotic. Additionally, 
by observing changes in biological activity associated with variation 
in the molecular framework of a series of analogues, structure-activity 
relationships may be determined. The last, and by no means least, 
justification is that such an endeavour is chemically challenging; as 
such it should result in increased knowledge of existing synthetic pro­
cesses, and could lead to new methodology.
It is well established that the ^-lactam antibiotics interfere 
with the synthesis of mucopeptide, the rigid structural component of 
bacterial cell walls. The antibiotic affects the final stage of muco— 
peptide synthesis, which is a crosslinking of peptidoglycan strands 
(Figure 1). In 1965 Tipper and Strominger proposed1 that the trans- 
peptidase enzyme responsible for this crosslinking falsely recognises 
the y3—lactam antibiotic as the terminal (D)—alanyl—(D)—alanine residue 
of a peptidoglycan strand. In doing so, it becomes irreversibly 
acylated, and thus inactivated. The similarities between the three- 
dimensional structures of penicillin, cephalosporin and (D)—alanyl—(D)— 
alanine are represented in Figure 2* Ulith inactivation of transpeptidase, 
and as it grows,the bacterium cell wall structure becomes increasingly 
disordered until it can no longer resist the high osmotic pressure of 
its contents; the cell then bursts.
Structure-activity relationships, in contrast, are but poorly 
understood. A striking example of this is presented by the cases of 
the 6 o( — methyl penam (2 a) and the 7c*.-methyl cephem (2b). Tipper
R C  O N H
E N Z
ENZ-SH
©
SCHEME 1.
RCONH
F I G U R E  3.
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and Strominger suggested that the spatial similarity between penicillin, 
cephalosporin and (D)—alanyl-(D)-alanine (Figure 2) could be increased 
by introduction of methyl groups at the 6 a -  and 7(X- positions, resp­
ectively, and therefore produce more powerful antibiotics. In 1971,
3
Bohem reported the synthesis of penam (2a) and cephem (2b); surprisingly, 
they were much less active than the naturally occurring parent compounds. 
However, there _is some correlation between antibiotic potency 
and chemical reactivity of the p -lactam ring towards nucleophiles,
4
This is especially evident for a particular series of cephalosporins 
and must be related to the ability of the antibiotic to acylate the 
transpeptidase (Scheme 1), The ability of the 3*-substituent, X, to 
influence the reactivity of the yS-lactam ring depends upon the following 
electronic effects. The degree of o'- and, more importantly, 7Y- 
electron withdrawal will influence the electrophilicity of the ^-lactam 
carbonyl carbon atom and also the stability of the transition state 
structure involved in opening of the y9 —lactam ring. Additionally, 
the tendency of the substituent to leave with a bonding pair of electrons 
will affect the ease of ring opening.
The target compound (1) of this research involves modification of 
position—1 of cephalosporin. Relatively little is understood about 
structure—activity relationships associated with this position. The 
role played by sulphur in the chemistry and biology of cephalosporin has
been the subject of considerable speculation for several years. The
5
delocalised structure (3) has been proposed as an intermediate in the 
solvolysis of the 3’-acetoxy group. The ultraviolet spectrum of cephal­
osporin exhibits an absorption at c<3. 260nm, which is of abnormally
6
long wavelength for a simple enamine system. It has been suggested 
that the sulphur d—orbitals contribute to the chromophore (Figure 3), 
to produce a bathochromic shift. In 1974, Topp and Christensen
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showed that the presence of the sulphur atom was not mandatory for
biological activity, the 1-carbacephalothin (4) exhibiting activity
comparable with natural cephalothin (5) (interestingly, the predicted
hypsochromic shift in the ultraviolet spectrum of analogue (4) was
indeed observed). Another important modification of position-1 of
cephalosporin is oxidation of the thio-ether to the two sulphoxides (6)
8
and (7). In general , the (S)-sulphoxide (6) is inactive; in contrast
the (R)-sulphoxide (7) retains biological activity, and in some cases
may be even more potent than the parent thio-ether. A recently report- 
g
ed exception to this generalisation is that the (S_)-sulphoxide (8) is
more active than the corresponding (<R)-sulphoxide.
An appraisal of the above information made 1-hydroxy-l-carbacep-
halosporin (1) an interesting synthetic target. The hydroxyl group
is ideally situated in at least one of the two possible carbinol epimers
for intramolecular hydrogen bonding"^ with the A^-double bond
(Figure 4). This could activate the ^-lactam ring by T/'-electron
withdrawal, and so produce a more potent antibiotic. Two approaches
to the synthesis of 1-hydroxy-l-carbacephalosporin (1) were investigated.
The first was based on the Lowe methodology,"^ which involves annela—
tion of a -lactam ring on to a preformed cyclic system via a carbene
insertion reaction (Scheme 2). The second route was modelled on the 
7bMerck and 5KF syntheses, cycloaddition of imines with ketene equiva­
lents being employed for j i —lactam ring formation (Scheme 3). The 
Lowe, Merck, and SKF synthetic strategies, and their use in the pre­
paration of nuclearly modified y3-lsctam ring systems are discussed in 
detail in the Introduction. The results of their application to the 
synthesis of 1-hydroxy-l-carbacephalosporin (1) are revealed below.
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1. Oxazolidone Approach
The less highly functionalised 3'-deacetoxy-l-hydroxy-l-carbacep— 
halosporin (9) was chosen as the initial synthetic target for several 
reasons. Although their activity is somewhat reduced, 3'-deacetoxy— 
cephalosporins are nevertheless potent antibiotics. Additionally, a 
reduction in functionality would facilitate the synthesis both by re­
ducing the number of necessary transformations, and by involving more 
tractable intermediates. Finally, if antimicrobial activity is ob­
served in the deacetoxy compound (9), then the acetoxy compound (1)
could be prepared either by allylic functionalisation or by modification
?
of the synthesis at an earlier stage. Preparation of the target com­
pound (9) by Lowe’s methodology (Scheme 2) requires a suitably pro­
tected tetrahydropyridine (10). This compound could be obtained in 
turn by intramolecular Wittig condensation of the keto—phosphorane (11). 
In this intermediate the amine and hydroxyl groups could be protected 
simultaneously by their incorporation into an oxazolidone ring system
i;
(12). When required, deprotection could be acheived by either acidic
13b 14or basic hydrolysis, or by hydride reduction. It should be
possible to prepare the phosphorane (12) from the oxazolidone (13) by
15
the glyoxylate condensation procedure developed by Woodward.
Oxazolidones can be prepared"^ by the reaction of epoxides with 
carbamates. A small amount of nucleophilic catalyst is necessary and 
a possible mechanism involves initial opening of the epoxide by the 
catalyst. To use this method to obtain the oxazolidone (13), one 
would require the epoxide (14) which, in turn, could be prepared by 
peracid oxidation of the j i  cf-unsaturated ketone (15). To avoid 
double bond conjugation, the alcohol (15) was employed as the starting 
material for the synthesis.
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The alcohol (16) was obtained by a published procedure involving 
Grignard reaction of allyl magnesium bromide with acetaldehyde. The nuc- 
leophilic hydroxyl group might be an unwelcome participant in the proposed 
oxazolidone ring formation and was therefore masked. The choice of mask­
ing group was constrained by the need for its subsequent removal from a 
target molecule (17) containing an oxazolidone ring system and an as yet 
unspecified carboxylic acid protecting group. The hydroxyl group was
therefore masked as the hydrogenolytically labile benzyl ether (18).
18Oxidation with permaleic acid, a reagent reported to be superior for 
the preparation of epoxides from terminal olefins, afforded the epoxide 
(19). Treatment with ethyl carbamate and a catalytic amount of triethyl- 
amine then produced the oxazolidone (20). This brought the synthesis to 
the stage where Woodward's procedure (Scheme 4) could be applied. The t— 
butyl, benzyl, £-nitrobenzyl, or trichloroethyl glyoxylate esters are 
normally used in this reaction sequence because they can be removed select­
ively from the sensitive cephalosporin nucleus. Since the oxazolidone (20) 
contains a hydroxyl group masked as its benzyl ether, only the _t-butyl and
trichloroethyl gloxylates are applicable; the former was chosen because
19
of its relatively simple preparation (Scheme 5). The oxazolidone (20)
was condensed with t—butyl glyoxylate (21) to give the hemiaminal (22).
20Model studies had indicated that the required oxazolidone-phosphorane 
could not readily be prepared but that the corresponding phosphonate (24') 
was more amenable to synthesis. Accordingly, the phosphonate was pre­
pared by treatment of the hemiaminal (22) with thionyl chloride to give 
the chloride (23) which, without purification, was heated with trim­
ethyl phosphite. Hydrogenolysis of the benzyl ether afforded the de­
protected alcohol (25). Conversion into the desired bicyclic oxazoli­
done (27) requires oxidation to the ketone (26) and intramolecular 
Emmons condensation. The presence of the acid labile t-butyl ester and
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the oxazolidone system necessitated mild oxidation conditions. Attempted
21
oxidation with Collins reagent gave, after chromatography, a low yield
of a mixture of methyl ketones as indicated by ^H-nmr. Oxidation with
22salver carbonate supported on Celite offered no improvement. The 
desired transformation was ultimately achieved using a low temperature, 
two-phase Oones oxidation. The spectral characteristics of the crude 
reaction product were consistent with formation of the ketone (26), 
However, attempted purification by even short-contact chromatography 
yielded enone (28), an apparently facile y^-elimination having cleaved 
the oxazolidone ring. The ketone (26) was therefore used without 
purification in an attempted cyclisation reaction. This unfortunately 
resulted only in decomposition of the keto—phosphonate, none of the 
desired bicyclic tetrahydropyridine (27) being detected. In hindsight, 
such a result is not surprising in view of the demonstrable lability of 
the ketone (26). To be successful, any transformation involving such 
a ketone would need to employ essentially neutral reaction conditions.
The corresponding Uittig condensation was therefore investigated. As 
anticipated, synthesis of the phosphorane (29) proved to be very diffi­
cult. After considerable variation of reaction conditions, the desired 
compound was prepared in satisfactory yield from the chloride (23) by 
heating under reflux in toluene with triphenylphosphine and lutidine. 
Unexpectedly, the benzyl ether could not be cleaved from the phosphorane 
(29) by hydrogenolysis. This problem was circumvented by performing 
the hydrogenolysis on the intermediate phosphoniurn salt (30). The 
resulting alcohol (31) was converted into the hydroxy-phosphorane (32) 
by treatment with sodium hydroxide. In view of the established lability 
of the keto-oxazolidone system it was decided to attempt oxidation and 
cyclisation without isolation of intermediates. Such a process has 
been described"*-5 for a similar system (Scheme 6). The hydroxy-
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phosphorane (32) was therefore treated with DMSO and acetic anhydride*
Tic Monitoring indicated that, by analogy with the oxidation of the 
hydroxy-phosphonate, oxidation had occurred and the mixture was there­
fore heated in an attempt to bring about cyclisation. No products of 
cyclisation were detected from this reaction, tic analysis indicating 
extensive decomposition. It may be that the small amount of acetic 
acid present is catalysing decomposition of the desired keto-phosphorane 
(33). Some effort should therefore be made to isolate this compound 
before subjecting it to the elevated temperatures required for UJittig 
reaction. Further investigation of this sequence was postponed because 
of developments in the alternative approach, which eventually led to 
the preparation of 1—substituted—1-carbacephem compounds. Nevertheless, 
this does not mean that the oxazolidone route should be abandoned. The 
bicyclic tetrahydropyridine carboxylic acid (34) has a three-dimensional 
structure very similar to that of cephalosporin, especially in the 
important c*-acylamino- c< -unsaturated acid region (Plate 1). This 
bicyclic compound may therefore possess interesting biological properties 
and has accordingly become a synthetic target in its own right.
Imine-Ketene Cycloaddition Approach
The second synthetic investigation of 1-hydroxy-l-carbacephalos- 
porin (1) was constructed around creation of the y?-lactam ring by re­
action of an imine with a ketene or its equivalent. The cycloaddition
23
reaction of imines with ketenes was initially discovered in 1907 by
. L t 24-26Staudinger. In more recent times, it has been studied extensively
by Bose and his collaborators. Although the mechanism of this reaction
is complex and incompletely understood, some empirical generalisations
can be made.
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27 28The reaction of an imine with a preformed ketene * involves a
zwitterionic intermediate (Scheme 7); such a pathway usually leads to
a trans—3,4—disubstituted ^ —lactam, On the other hand, reaction with
an activated carboxylic acid derivative probably proceeds via an acyl
iminium salt (Scheme 8); triethylamine will then remove an oc—proton,
and the resulting cyclisation will lead to a mixture of cis- and trans-
3,4-disubstituted ^-lactams. The ratio of cis to trans isomers obtain-
24ed depends upon several factors, including the mode of addition of 
reagents; addition of acid chloride to a mixture of imine and triethyl­
amine favours cis-disubstitution whereas addition of triethylamine to a 
solution of imine and acid chloride favours trans-dlsubstitution. In
those cases in which the acid chloride carries an -substituent with
a lone pair of electrons, mixtures of cis- and trans-y^-lactams are
26obtained, otherwise the trans—isomers are normally observed. The
nature of the imine substituent R1 is also important; when R* is a
29
thioalkyl group trans—disubstituted products predominate , when it is
7b
an alkyl chain cis-disubstitution is the major isomer , and when it
24
is an aromatic group cis-trans mixtures of isomers are obtained. The
outcome of this reaction is further complicated in that the two general
pathways outlined in Schemes 7 anti- 8 are not necessarily exclusive,
mixed pathways being highly probable in some cases.
The Werck group have employed cycloaddition of an imine and a
7b
ketene equivalent in a synthesis of 1-carbacephalothin (Scheme 9).
20The results of a previous attempt to adapt this synthesis to the pre­
paration of 1-hydroxy-l-carbacephem structures strongly influenced the 
direction of the present work; these are therefore summarised below.
The aldehyde (35), in which the terminal double bond permits introduct­
ion of the requisite functionality at a later stage, was chosen as one 
of the key building blocks. Condensation with the amine (36) then gave
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the imine (37)* This imine was treated with azidoacetyl chloride and 
triethylamine under a considerable range of reaction conditions, but 
the desired y#-lactam (39) was never detected in these reactions, the 
sole products being the acylated amine (38) and the starting aldehyde 
(35) (Scheme 10)* To account for these results, it was proposed that 
the initially formed adducts (40) and/or (41) could undergo either base 
abstraction or proton transfer of the highly acidic proton H to form
H
in both cases the ylid (42) (Scheme 11)* This ylid will lie in a 
thermodynamic well on the reaction coordinate, and the driving force 
for cyclisation will then be lost. On isolation, protonation of the 
ylid (42) will reform the reactive iminium ion (40) which will be hydro­
lysed immediately to the observed products, the aldehyde (35) and the 
amide (38)* This particular investigation was therefore abandoned.
Recently, chemists at SKF have developed"^ a method for the pre­
paration of yj—lactams via imine + ketene cycloaddition in which the 
amine component of the imine can be regarded as equivalent to ammonia 
itself (Scheme 12). If the above rationalisation is correct, the SKF 
methodology should offer a solution to the problem of j3 —lactam formation* 
The imine (43) which would be formed by condensation of the aldehyde (35) 
with 2,4—dimethoxybenzylamine does not possess such a highly acidic pro­
ton as before, and the formation of the ^ — lactam (44) should therefore 
be relatively uncomplicated. Continuation of the SKF route would
furnish the deprotected jS —lactam (45) (Scheme 13). After reduction
15
of the azide and acylation, application of Woodward's procedure 
(Scheme 14) would give a compound (46) functionally equivalent to the 
-lactam (39) which could not be obtained directly. Recently, Durst 
has reported^ that 4—(3’—butenyl)azetiain—2-one (47) undergoes a novel 
cyclisation to give carbapenam structures (48) when treated with electro— 
philes such as iodine or mercuric acetate. This makes the ^-lactam
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(45) additionally attractive since it could be converted by such a 
procedure into 1-hydroxy-l-carbapenam analogues (Scheme 15),
To return to the investigation of -lactam formation, the alde­
hyde (35) was prepared as follows. The glyoxylate acetal (49) was 
converted into the piperidide (50), which was subjected to a Grignard
reaction with allyl magnesium chloride to give the -unsaturated
31ketone (51). This is a modification of a preparation of the methyl 
ketone (52). The unsaturated ketone (51) proved to be extremely labile 
with regard to double bond conjugation and was therefore reduced directly 
at low temperature to the alcohol (53). Protection of the alcohol as 
its benzyl ether (54) and acid-catalysed hydrolysis of the acetal then 
gave the required aldehyde (35). The imine (43) was obtained by con­
densation of the aldehyde with 2,4-dimethoxybenzylamine. Treatment of 
a mixture of this imine and triethylamine in THF at -78°C with azido- 
acetyl chloride resulted most gratifyingly in efficient y3-lactam form­
ation. Chromatographic separation furnished pure cis-ff-lactam (55), 
and a mixture consisting of equal amounts of cis-yg-lactam (55) and 
trans— f t -lactam (56), in a ratio of 2:1 respectively. The stereo-
32
chemical assignment was based on the observed 'H—nmr coupling constants 
of a one proton doublet at§4,5ppm (H.)j these were 3=5Hz in the cis—
n
isomer (55) and J=2Hz in the trans-isomer (56).
The lability of these monocyclic y^-lactams encouraged the thought
that reduction of the azide followed by acylation might confer some
stability and thus improve the chance of success in the oxidative removal
of the dimethoxybenzyl group. Azides are usually reduced to amines by
catalytic hydrogenation, but this could additionally cleave the benzyl
ether protecting group, and would reduce the terminal double bond.
33
However, 3—azidoazetidin—2—ones have been reduced by treatment with 
a combination of hydrogen sulphide and triethylamine; this method
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proved successful for the reduction of the cis—fused azido—y^—lactam 
(55)* The resulting amine was treated, without isolation, with 
phenoxyacetyl chloride to give the stable crystalline acetamido—y#- 
lactam (57); additional amounts of this compound could be obtained by 
reduction and acylation of the cis—trans mixture, followed by fraction­
al crystallisation.
When the protected y3 -lactam (57) was subjected to the conditions 
reported"^ for the removal of the dimethoxybenzyl group, the deprotected 
compound (58) was not obtained. The only discrete product isolated was
2,4-dimethoxybenzaldehyde (59), indicating that deprotection had cert­
ainly occurred. Tic Analysis of the crude reaction products showed 
the presence of dimethoxybenzaldehyde, together with highly polar 
material, suggestive of considerable decomposition having taken place. 
Extensive variation of the reaction conditions, including the addition 
of silver nitrate^, did not alter the outcome. Benzylic^ or allylic 
oxidation of the other active methylene positions in lactam (57) may 
well be complicating the deprotection, which, to date, has still not 
been achieved. Although this apparent dead end was met with disappoint­
ment, the success of the J3 -lactam formation itself prompted a reinvest­
igation of the synthesis of lactam (39), employing the same reaction 
conditions.
The required amine component (36) was therefore prepared in the
following manner. Condensation of phthalimide and formaldehyde gave
the hemiaminal (60), which was converted into the bromide (61). An
Arbusov reaction with triethyl phosphite then gave the phthalimido—
phosphonate (62), which was subjected to hydrazinolysis. The result—
3 6ing aminomethylphosphonate (63) was both protected and activated as 
its Schiffs base (64). C-Acylation with benzyl chloroformate using 
lithium isopropylcyclohexylamide as base afforded the glycine derivative
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(65). Deprotection then gave the required amine component (36). The
sequence from amine (63) to the acylated species (36) is a modification 
37
of the reported procedure.
When the amine (36) was condensed with the aldehyde (35) and the 
resulting imine treated with azidoacetyl chloride under the previously 
successful cycloaddition conditions, a low yield (5%) of the desired 
p —lactam (39) was obtained. The !H-~nmr spectrum of this compound 
was broad and unresolved, indicating that a gross mixture of stereo­
isomers was present, although this was not apparent from its behaviour 
on tic analysis. Initially it was believed that this product was a 
mixture of cis- and trans-3,4-disubstituted p - l a c tarns; the results 
of subsequent transformations on a similar series of compounds will 
indicate that this assumption is probably incorrect.
On subsequent repetitions of the cycloaddition reaction the yield 
of lactam varied between 0 and 5%, despite strenuous efforts to maintain 
constant reaction conditions. In an attempt to obtain the p —lactam 
(39) on a preparative scale, the reaction conditions were subjected to 
extensive investigation. The order of addition of the reactants was 
varied, ranging from modes thought to favour pre-formation of a ketene 
(addition of the imine to a solution of azidoacetyl chloride and trieth— 
lamine) to modes where the iminium salt is pre-formed (addition of trie­
thylamine to a mixture of the imine and azidoacetyl chloride). No 
improvement in yield was attained; moreover, for any particular order 
of addition, the yield observed was not reproducible. It would there­
fore appear that the desired ^-lactam (39) is occurring only as a side- 
product in this reaction, the main product being the amide (38).
Since the formation of the N-dimethoxybenzyl substituted ^-lactam 
(55) is a facile process, whereas the formation of the N-phosphonato— 
acetate substituted Z^-lactam (39) is extremely intractable, it is
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apparent that the explanation proposed for the difficulties previously 
encountered is correct. This encouraged speculation as to how the 
formation of the thermodynamically favoured intermediate (42) might be 
precluded. If this intermediate arises via intermolecular proton trans­
fer in the initial adduct (41) the rate of such a process could be reduc­
ed by decreasing the concentration of reactants. Also, an increase 
in the reaction temperature could increase the amount of kinetic product 
(^3-lactam) formed from either adducts (40) or (41). However, before
these speculations were tested experimentally a literature-search revealed 
38
a publication by the Merck group, in which they reported formation
of a y3-lactam (66b) in which the reaction conditions had been altered
7b
drastically from those previously reported for formation of the close­
ly-related lactam (66a) outlined earlier in Scheme 9. The original 
conditions involved addition of an ethereal solution of the imine (67) 
to a solution of azidoacetyl chloride and triethylamine in ether at 
-78°C, whereas the conditions reported three years later involved slow 
addition of a cyclohexane solution of azidoacetyl chloride to a dilute 
solution of imine (67) and triethylamine in benzene—cyclohexane, at 
25°C, In the former reaction, the yield of -lactam was 30/1 and in 
the latter 54/b, Interestingly the new conditions involve a reduction 
in reactant concentration and an increase in reaction temperature,
When these conditions were applied to the case in hand, the desired 
lactam (39) was obtained in the very respectable yield of 42/e.
With the problem of y#-lactam formation overcome, consideration 
was then given to functionalisation of the terminal double bond, which 
requires overall oxidation to an oC—acetoxy ketone (Scheme 16), Similar
transformations^’^  have been reported (Scheme 17), but these are 
multistep processes usually involving both acidic and basic reagents.
It was considered inappropriate to subject a compound such as lactam
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(39), containing as it does a reactive azido group and a potentially
acidic hydrogen atom, to such a protocol; accordingly an alternative
oxidation procedure was sought. Ozonolysis offers the most direct
oxidation of an olefin to a carbonyl compound, and furthermore has
33
been performed on an azetidinone (68) with an azido substituent and 
also on ^ —lactam structures (69) containing^ a phosphonium-activated
sis, in the expectation that the aldehyde (70) could thus be readily
prepared. This modification to the synthetic strategy was thought
desirable because it would very quickly give a compound which could be
used to investigate the proposed intramolecular Emmons condensation to
give, in this case, cephem (71). There was some anxiety that this
base—induced reaction might be complicated by ^ —elimination of benzyl
alcohol in a process similar to that observed in the attempted Emmons
condensation in the earlier oxazolidone route. The preparation of the
cephem (71) need net be considered only as an academic exercise since
completion of the planned synthesis (Scheme 18) would give the 3-des—
42
methyl analogue (72); similarly unsubstituted cephems are known to 
possess good antibacterial activity.
Ozonolysis of lactam (39) followed by reductive treatment with 
dimethyl sulphide^ gave a compound which on tic analysis was shown not 
to be starting material but whose nmr and ir spectra did not reveal the 
presence of an aldehyde function. It was therefore presumed that'ozono­
lysis had produced a relatively stable ozonide. In a sesquiterpene
44synthesis, Isobe has reported that ozonolysis of the terminally 
olefinic compound (73) gave an ozonide which could not be reduced by 
dimethyl sulphide, but which was reduced to the corresponding aldehyde 
on treatment with triethylamine. Unfortunately, triethylamine did 
not reduce the ozonide obtained from lactam (39). In view of the
proton. to ozonoly-
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failure of these mild and selective reducing agents, more powerful
reagents were employed in the hope that the ozonide would be more labile
towards reduction than either the azido or benzyl groups. Ozonolysis
45
followed by treatment with triphenylphosphine - or catalytic hydrogena- 
46
tion did not produce aldeydic compounds but instead gave very polar 
products indicating that reduction of the other functional groups had 
indeed occurred.
An appraisal of the mechanism of ozonolysis was necessary to help
devise a method of avoiding the formation of such a stable ozonide.
47Criegee has studied the ozonolysis reaction extensively and has arrived 
at the following conclusions. Ozone reacts with the olefin to form an 
unstable molozonide (74), which fragments to give a zwitterion (75) 
and a carbonyl component (76) (Scheme 19). The carbonyl component is 
usually derived from the less substituted olefinic carbon and the ultim­
ate fate of the zwitterion depends on three factors; its structure, 
its environment, and the structure of the carbonyl component. Protic 
solvents such as methanol usually react with the zwitterion to give 
hydroperoxides (77) in high yields. In inert solvents the zwitterion 
may dimerise to give diperoxides (78), or polymerise, or react with 
the carbonyl component (76) to give the classical ozonide (79). This 
last process is particularly dependent upon the structure of the carbonyl 
component and, in general, only occurs where the carbonyl compound 
is an aldehyde.
The stability of the ozonide obtained from lactam (39) indicated 
that a structure of type (79) was being formed by reaction of the 
zwitterion with the carbonyl component, formaldehyde. It was specul­
ated that this process might be obviated by increasing the substitution 
pattern of the olefin. The simplest and most appropriate increase in 
substitution is seen in the methyl homologue (80) of lactam (39); this
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would give the 3—methyl cephem analogue (9) on successful completion 
of the proposed synthetic strategy (Scheme 20)* This compound more 
closely resembles the natural cephalosporin skeleton and, indeed, has 
been discussed previously as a synthetic target.
Simultaneously with the preparation of lactam (80), the remaining
supply of desmethyl lactam (39) was subjected to ozonolysis, followed 
33
by treatment with NaBH^ , in the hope that the ozonide would be reduced 
to the alcohol (83). Unexpectedly, the initial reduction product, 
the phosphonato-aldehyde (70), underwent intramolecular condensation 
in the basic medium at a rate greater than that of further reduction.
The product isolated from this reaction was surprisingly the cephem (71). 
There was insufficient material to allow the determination of the stereo­
chemistry and this result, though interesting, was not investigated 
further because of developments in the homologous series.
The methyl analogue (80) of j3 -lactam (39) was prepared via the 
intermediates (84) to (87) by substituting methallyl chloride in place 
of allyl chloride and performing the synthesis as before (Scheme 21).
The compound (80) so obtained exhibited similar physical characteristics 
to its desmethyl parent (one spot on tic and a largely unresolved fH—nmr 
spectrum) and again it was assumed that a cis—trans mixture of jS —lactams 
had been obtained. Ozonolysis, followed by treatment with dimethyl 
sulphide now gave the ketone ( 81) smoothly and in virtually quantitative 
yield. Analytical tic examination of this ketone showed two overlapping 
components which were assumed to be the cis- and trans- disubstituted 
isomers. Some effort was expended in obtaining pure samples of each; 
separation was achieved on a small scale by preparative tic employing 
multiple elution. The fH-nmr spectra of both components were very 
complicated, with doubling of signals indicating that each was a mixture 
of diastereoisomers, and no relative stereochemical assignments could
-52-
be made at this stage. In view of this, and in the expectation that 
separation would become easier after cyclisation (if only because this 
destroys one chiral centre), no attempt was made to obtain the individ­
ual components of the mixture of ketones on a preparative scale.
When the mixture was treated with sodium hydride in DME and heated 
at 50°C, cyclisation of one of the diastereoisomeric components was 
observed to occur. After chromatographic separation, this gave a cry­
stalline carbacephem compound (88) and a diastereoisomeric mixture of 
ketones whose 'H-nmr spectrum was superimposable with that of the more 
polar of the two separated ketones. The melting point of the cyclised 
product (88) was extremely sharp, suggesting that it was not a diaster— 
eoisomeric mixture but was a single compound. Its relative stereoche­
mistry was assigned on the basis of ’H-nmr coupling constants (see 'H-nmr 
opposite), which were determined using scale expansion and decoupling 
techniques. The coupling constant of 3 ^ = 4.5Hz for the ^-lactam 
6,7-protons is characteristic of cis-6,7-disubstitution. With this 
established, it then became possible to ascertain the relative stereo­
chemistry at C-l by examining the vicinal coupling constants associated
with H •
c
The coupling constant of 3^c = 8.5Hz is very large, indicating
a trans orientation of H and H, in which the dihedral angle approaches 
— ■ c b
180°. This relative configuration of Hc is further evidenced by its 
coupling with the methylene protons H^ and Hg; here there is one large 
coupling constant 3 ^ = 8.5Hz and a slightly smaller one 3cg = 6Hz.
In the alternative configuration for the substituent at C-l these 
coupling constants would be approximately equal and small. The appear­
ance of the benzyl ether benzylic protons as a sharp two-proton singlet 
lends further support tD the (X -configurational assignment for this 
substituent, such equivalence indicating that it is rotating freely*
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In the alternative ^-configuration, it will be seen (vide infra) that 
free rotation is restricted by intramolecular interaction between the 
benzyloxy and the azido groups.
The assignment of the benzyloxy and azido substituents to opposite 
faces of a carbacephem in which the 6,7—disubstitution is cis can account 
for the isomer selectivity observed in the cyclisation reaction. Cont­
rary to what had been assumed previously,y^-lactam ring formation must 
have resulted in exclusive cis—3,4-disubstituted products, -and the 
individual diastereoisomeric ketone components must therefore have been 
the benzyloxy epimers (89) and (90). As Emmons cyclisation takes place 
(Scheme 22), considerable conformational rigidity will be created at 
an early stage in the reaction coordinate. In isomer (90), this will 
introduce a comparatively unfavourable steric interaction between the 
azido and the benzyloxy substituents, resulting in a higher activation 
energy requirement for production of carbacephem (91). There will be 
no such unfavourable interactions in the pathway leading from isomer 
(89) to carbacephem (88), and the observed selective production of this 
bicyclic epimer under mild conditions is therefore unsurprising.
Such an interpretation required cyclisation of the recovered un­
reacted keto-phosphonate isomer (90) for verification. This was achiev­
ed by similar treatment with NaH in DME, but at an elevated reaction 
temperature, to give carbacephem (91). The 'H-nmr of this compound 
(see.opposite) again includes a characteristic cis—coupling constant of 
= 5Hz for the ^-lactam protons. As expected, all the vicinal 
coupling constants associated with Hc are small, as anticipated if the 
benzyloxy and azido substituents occupy the same face of the molecule. 
This is further evident from the non-equivalence of the benzylic protons 
of the benzyl ether, which appear as an AB quartet, indicating that
0 C H0 P h
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there is restricted rotation at this position. Additionally, the 
aromatic protons of this moiety now occur as a broadened multiplet 
indicative of some rotational immobility. It is therefore evident that 
P -lactam ring formation resulted in cis-3,4-disubstitution exclusively; 
by analogy, this was also the case in formation of the desmethyl j 3 — 
lactam (39).
Reduction of the 7 -azido-1cx-benzyloxycarbacephem (88) with 
hydrogen sulphide/triethylamine to the corresponding amino compound
(92) followed, without purification, by acylation gave the 7y3-phenoxy—
acetamidocarbacephem (93). Disappointingly, hydrogenolysis did not
produce the target 1-hydroxy-l-carbacephem (94), but instead gave the
3
mono-deprotected compound (95). Reduction of the A  -double bond 
(as evidenced by the gradual appearance in the 'H-nmr spectrum of a 
doublet at c>1.2 ppm) was occurring before there was any indication of 
benzyl ether cleavage. The addition of TFA to the hydrogenolysis mix­
ture did not alter the course of the reaction. The epimeric cephalo- 
sporanic acid analogue (97) was similarly obtained from the azido com­
pound (91), via the protected carbacephem (96) (Scheme 23).
48
Trimethylsilyl iodide has been reported to be a mild and select­
ive reagent for the removal of benzyl esters and ethers from labile 
peptide compounds. However, treatment of the protected carbacephem
(93) with this reagent led to extensive decomposition of the starting 
material.
The nuclearly modified cephalosporin analogues (95) and (97) were 
tested for antibiotic activity against a strain of S. aureus. The 1 0< — 
isomer (95) produced a 1mm zone of total inhibition at a concentration 
of lmg per ml using the agar well method for determining susceptibility; 
the 1 /3-isomer was inactive at this concentration.
-55-
This project has been successful in the synthesis of oxygenated
1—carbacephalosporin analogues. Only removal of a protecting group
impedes attainment of the target 1-hydroxy-l-carbacephalosporins.
Deprotection, though occasionally troublesome, is rarely an insurmount
able problem in a molecule of this size. The wealth of protecting
groups available and the variety of methods employed for their removal
usually enable modification of a synthesis to overcome such difficulties
49
Electrochemical oxidation is one particularly promising method of 
benzyl ester and ether cleavage which has yet to be explored. Time 
has not permitted such an investigation which now becomes the responsi­
bility of nr. A. McLeod who is continuing this research.
Experimental
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General Experimental and Abbreviations
Melting points are uncorrected and were determined on a Kofler hot 
stage apparatus. Microanalyses were obtained by Mrs. Harkness and her 
staff. Mass spectra were recorded by Mr. A. Ritchie on A.E.I. - G.E.C./ 
MS 12 and A.E.I. - G.E.C./MS 902 mass spectrometers. Routine ir spectra 
were recorded on a Perkin Elmer 197 grating spectrophotometer and were 
liquid film. Solution and KBr disc ir spectra were obtained using a 
Perkin Elmer 580 grating spectrophotometer. Routine nmr were recorded 
on a Uarian T 60 and high resolution nmr spectra were recorded on a 
Perkin Elmer R32 spectrometer, with tetramethyl silane as internal 
standard in both cases.
Kieselgel G (Merck) was used for preparative tic and, unless 
otherwise stated, Silica TSC (Uloelm, Grade III) was used for column 
chromatography. Analytical tic plates were stained with eerie sulphate 
followed by heating to approximately 150°C.
All dilute mineral acids were 6i\! aqueous unless otherwise stated. 
Light petroleum refers to the fraction boiling in the range 40—60 C.
All organic solutions were dried, unless otherwise stated, over anhyd­
rous magnesium sulphate.
Tetrahydrofuran and dimethoxyethane were heated under reflux with 
lithium aluminium hydride and distilled prior to use. Ether, benzene 
and toluene were dried over sodium wire. Methylene chloride was dried 
by percolation through a column of alumina ('jJoelm, Grade I basic).
The following abbreviations and symbols have been used throughout 
this section.
tic thin layer chromatography 
ir infrared
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nmr nuclear magnetic resonance
uv ultrav/iolet
s singlet
d doublet
t .triplet
q quartet
m multiplet
b broad
H+ molecular ion
Oxazolidone Approach
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4-Hydroxypent-l-ene (16)
This was prepared by the published procedure , and was obtained 
as a colourless oil bp 119° C at 760 mmHg (lit. bp 115—116 C at 760 mmHg).
£(CDC13) 1.1 (3 H, d, 3 5 Hz, CH3) 2.21 (2 H, d t, 3 7 Hz and
3 2 Hz, -CH2“ ), 3.2 (1 H, bs, exchanges with D20, OH),
3.4-4.0 (1 H, m, CHOH), 4.9-5.3 (2 H, m, CH=CIH2), and
5.5-6.2 (1 H, m, CH=CH2).
4-Benzyloxypent-l-ene (18)
To a stirred suspension of sodium hydride (9.0 g, 100^, 0.38 mol) 
in THF (150 ml) was added 4-hydroxypent—1-ene (16) (30 g, 0.37 mol) 
dropuise over 30 min with stirring in an atmosphere of nitrogen. The 
mixture was heated under reflux for 2 h then cooled to 0°C, when a 
solution of benzyl bromide (63.6 g, 0.37 mol) in THF (30 ml) was added 
dropuise with stirring over 30 min. The mixture was heated under reflux 
for a further 2 h, then allowed to stand for 18 h at room temperature. 
Ethanol was added dropuise to quench excess sodium hydride and the 
reaction mixture poured on to water (250 ml). The aqueous solution was 
extracted uith ether (2 x 500 ml) and the combined organic extracts 
washed with brine, dried and concentrated _in vacuo. Distillation of 
the residue afforded the benzyl ether (18) as a colourless oil (53.6 g, 
87%) bp 94°C at 2 mmHg.
^  max 3065, 3030, 1640, 1450, 1170, 1140, 1125, and 1090
-1cm •
^ (CDC1 ) 1.22 (3 H, d, 0 6 Hz, CH3), 2.35 (2 H, m, -CH2-),
3.61 (1 H, q, 0 6 Hz, CH0), 4.6 (2 H, s, CH^Ph), 4.9-
-62—
5.3 (2 H, m, CH=CH2), 5.6-6.2 (l H, m, CH=CH2), and
7.3 (5 H, s, Ph)
(Found: C, 81.9; H, 9.3. C12H16° recluires c» 81*7> H, 9 ,2 % ),
l,2-Epoxy-4-benzyloxypentane (19)
To a solution of maleic anhydride (7.46 g, 76 mmol, freshly dis­
tilled) in methylene chloride (30 ml) at 0°C was added hydrogen peroxide 
(2.3 g, 90%, 66 mmol) in one portion with stirring. The solution was
stirred at this temperature for a further 2 h, and a solution of 4-
benzyloxypent-l-ene (18) (7 g, 40 mmol) in methylene chloride (7 ml) 
was added dropwise at 0 C. The mixture was stirred at this temperature 
for 14 h, filtered, and the filtrate washed with saturated aqueous 
NaHCO^ solution, brine, and dried. The solvent was removed under 
reduced pressure and the residue distilled to furnish a mixture of the 
diastereoisomeric epoxides (19) as a colourless oil (6.3 g, 82%), bp 
100°C at 1 mmHg.
Vmax 1460, 1380, 1350, 1130, 1100, 1070, and 1030 cm \
S(CDC13) 1.26 (3 H, d, 3 6 Hz, CH3), 1.28 (3 H, d, 3 6 Hz,
CH3), 1.47-3.7 (12 H, m, 2 x CH^-CHCH2CH), 4.53 (4 H, 
bs, 2 x CH^Ph), and 7.35 (10 H, s, 2 x Ph).
(Found: C, 74.9; H, 8.6. CloH,^0o requires C, 74.9; H, 8.4%).
1Z lb Z
Preparation of the Oxazolidone (20)
A mixture of the epoxide (19) (22.5 g, 0.12 mol), ethyl carbamate
(15 g, 0.17 mol) and triethylamine (2.25 g, 0.022 mol) was heated for 
4 h at 110°C in a tube sealed with a Teflon valve. Column chromato­
graphy (eluting solvent ethyl acetate - light petroleum) of the crude
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reaction product on alumina (Uoelm, Grade III acidic) afforded the 
oxazolidone (20) as a pale yellow oil (15 g, 55^) which gave white
o
needles mp 46-49 C on crystallisation from ether,
\Tmax 3380, 1750, 1490, 1450, 1375, 1230, 1070, and 1030 cm"1;
S(CDC13) 1.22 (3 H, d, 3 7 Hz, CH3), 1.24 (3 H, d, 3 7 Hz, CH3 ),
1.6-2.1 (4 H, m, 2 x -CH2«), 3.2-4.0 (8 H, m, 2 x 0CH 
CH2N and 2 x CHOCH^h), 4.48 (2 H, s, CH2Ph), 4.52 
(2 H, s, CH2Ph), 6.35 (2 H, bs, 2 x NH), and 7.35 
(10 H, s, 2 x Ph).
(Found: C, 66.1; H, 7.4; N, 5.75. C^3H^203N requires C, 66.4; H, 7,3;
N, 5.95JS).
t—Butyl Glyoxylate (21)
This was prepared by the literature method and was obtained as 
a colourless oil, bp 76°C at 30 mmHg (lit. bp 59—61°C at 20 mmHg), as 
a 1:2 mixture of the aldehyde (21) and its hydrate.
Preparation of the Hemiaminal (22)
A solution of the oxazolidone (20) (7 g, 29.8 mmol), _t—butyl 
glyoxylate (3.85 g, 29.6 mmol) and triethylamine (5 drops), in toluene (50ml) 
was heated under reflux for 18 h. The mixture was concentrated in 
vacuo and the crude reaction product purified by column chromatography 
(eluting solvent ethyl acetate - light petroleum) to give the hemiaminal 
(22) as a pale yellow oil (7.1 g, 66%)»
Vmax 3320, 1750, 1740, 1370, 1230, 1150 and 1060 cm""1.
<£(CDC13) 1.2 (3 H, m, CH3), 1.5 (9 H, s, BlA), 1.9 (2 H, m,
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-CH2-), 2.8-3.8 (4 H, m, OCHCH^N and CHOCH^h), 4.5 
(2 H, m, CH2Ph), 5.5 (l H, s, OH), and 7.35 (5 H, s,Ph) 
(Found; m/e 321. c15H1gN05 requires M, 321).
Preparation of the Phosphonate (24)
To a solution of the hemiaminal (22) (2.2 g, 6 mmol) and lutidine 
(0.77 ml, 6.6 mmol) in THF (40 ml) in an atmosphere of argon was added
O
thionyl chloride (0.48 ml, 6.6 mmol) dropuise with stirring at -10 C.
The solution was stirred for 1 h at room temperature and then filtered.
To the filtrate was added trimethyl phosphite (1.6 g, 12.3 mmol) and the 
mixture heated under reflux for 16 h. Volatiles were removed in vacuo. 
Column chromatography (eluting solvent ethyl acetate — light petroleum) 
of the residue on alumina (Woelm, Grade III, neutral) afforded the 
phosphonate (24) as a pale yellow oil (1.5 g, 55/).
Vmax (CHCl^) 1760 (shoulder), 1730, 1370, 1230, 1150, and 
1060 cm”1.
£(CDC13) 1.62 (9 H, s, Bit—), 3.85 (6 H, 2 X d, UH_p 11 Hz,
2 x OMe), 5.0 (1 H, d, JH__p 24 Hz, CHP0), and 7.35 
(5 H, s, Ph).
(Found; m/e, 401.12380. C3_7H24°8PI'’J ^ ”C4H8^ recluires 401.12392).
Preparation of the Alcohol (25)
To a solution of the benzyl ether (24) (300 mg, 0.66 mmol) in ethyl 
acetate (30 ml) was added 10/ Pd/C (300 mg) and the mixture stirred for 
5 days under 1 atmosphere of hydrogen. The solution was filtered and 
volatiles removed i_n vacuo to give the alcohol (25) as a colourless oil 
(215 mg, 90/).
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\fmax (CHC13 ) 3470, 1760 (shoulder), 1735, 1370, 1250, 1150,
and 1040 cm \
C>(CDC13) 1.23 (3 H, d, CHgCHOH), 1.54 (9 H, s, Bi£), 2.5
(1 H, bs, exchanges with D20, OH), 3.85 (6 H,
2 x d, 3U n 11 Hz, 2 x OCHj, and 5.0 (1 H, 2 X d,
H—r J
3U _ 26 Hz, CHPO)•
H — r  “ *
(Found; P'l+, 367.13968. C^H^NOgP requires n, 367.13957).
Oxidation of the Alcohol (25)
To a solution of the alcohol (25) (300 mg, 0.82 mmol) in benzene (3ml) 
at 10°C was added Jones' reagent (2W, 1.65 ml) and the mixture was 
stirred at 10°C for 45 min. The solution was diluted with benzene, 
washed with brine, dried and concentrated in vacuo to give the ketone 
(26) as a pale yellow oil (176 mg, 59%).
Vmax (CHClg) 1740 (b), 1720, 1370, 1250, 1150, 1060, and
1040 cm”1.
c)(CDC13 ) 1.45 (9 H, s, BiA), 2.15 (3 H, s, CHgCO), 3.8
(6 H, 2 x d, 3H_p 11 Hz, 2 x one), and 4.9 (1 H,
2 x d, 3U n 26 Hz, CHPO).
H—P —
Attempted purification of this compound by preparative tic
(developing solvent ethyl acetate) resulted in -elimination and loss
of carbon dioxide to give the <*j3 -unsaturated ketone (28).
"\Tmax (CHClg) 1730, 1680, 1630, 1450, 1370, 1250, 1150, and
-1ICjO cm .
£(CDC13) 1.45 (9 H, s, BlA), 1.85 (l H, bs, NH) 2.2 (3 H,
s, CHgCO), 3.85 (6 H, 2 x d, 3H_p 11 Hz, 2 x OCHg), 
and 6.2-7.0 (2 H, m, CH=CH)
(Found; H+ , 321. C, ,,H0 ,0,.1\1 requires H, 321).
1J Z 4 b
■66.
Attempted Intramolecular Emmons Condensation of Keto-Phosphonate (26)
A solution of the keto-phosphonate (26) (195 mg, 0,5 mmol) in THF 
(20 ml) was added, in one portion, to a slurry of sodium hydride
O
(14 mg, 0.55 mmol) in THF (20 ml) at -40 C. The mixture was stirred
and allowed to warm up to room temperature. It was then heated under
reflux, with tic monitoring, until all the starting material was con­
sumed (16 h). The mixture was poured onto water and extracted with 
ether. The combined ethereal extracts were dried, and concentrated 
in vacuo to give a mixture of polar products, none of which could be 
identified.
Preparation of the Phosphorane (29)
To a solution of the hemiaminal (22) (1 g, 2.7 mmol) and lutidine 
(0.35 ml, 3 mmol) in THF (20 ml), under an atmosphere of argon, was
°added thionyl chloride (0.22 ml, 3 mmol) dropwise with stirring at -10 C. 
The mixture was stirred for 2 h at room temperature, filtered, the 
filtrate concentrated in vacuo, and redissolved in toluene (20 ml). 
Triphenylphosphine (0.72 g, 2.7 mmol) was added and the mixture heated 
under reflux, in an atmosphere of argon, for 40 h. The reaction mix­
ture was evaporated Ln vacuo, and the residue partitioned between water 
and ether. The separated aqueous layer was basified with dilute sodium 
hydroxide solution and extracted with ethyl acetate. The combined ethyl 
acetate extracts were dried, and concentrated in_ vacuo. Column chrom­
atography (eluting solvent ethyl acetate - light petroleum) afforded the 
phosphorane (29) as a white foam (0.85 g, 51>l).
-67-
^fmax (CHC13 ) 1745 (shoulder),. 1640, 1440, 1240, 1170, and
1110 cm
S  (CDC13 ) 0.8 (9 H, s, Bu—•), 7.35 (5 H, s, 0CH2£h), and
7.5-7.7 (15 H, bm, PPh3 )
(Found: N+, 609.26404. ^yH^C^NP requires M, 609.26438).
Attempts to remove the benzyl ether from this compound by hydro— 
genolysis were unsuccessful.
Preparation of the Hydroxy-Phosphorane (32)
To a solution of the hemiaminal (22) (1 g, 2.7 mmol) and lutidine 
(0.35 ml, 3 mmol) in THF (20 ml) under an atmosphere of argon, was
o
added thionyl chloride (0.22 ml, 3 mmol) dropwise with stirring at -10 C. 
The mixture was stirred for 2 h at room temperature, filtered, con­
centrated in vacuo and redissolved in toluene (20 ml). Triphenylphos- 
phine (0.72 g, 2.7 mmol) was added and the mixture heated under reflux, 
in an atmosphere of argon, for 40 h. The reaction mixture was evapor­
ated in vacuo and the residue triturated with ether to give the-crude 
phosphonium chloride (30) as a white foam.
S"(C0C13 ) 1.85 (9 H, s, Bu~), 7.35 (5 H, s, 0CH2£h), and 7.4-
8.2 (15 H, bm,PPh3).
This was dissolved in ethanol (25 ml) and 10% Pd/C (600 mg) 
catalyst added to the solution. The mixture was stirred in an atmos­
phere of hydrogen (50 psi) for 5 days, filtered, and volatiles removed 
in vacuo. The residue was dissolved in water and extracted with ether. 
The separated aqueous layer was basified with dilute sodium hydroxide 
solution and extracted with ethyl acetate. The combined ethyl acetate 
extracts were dried and concentrated in vacuo. Column chromatography
-68-
(eluting solvent ethyl acetate - light petroleum) of the residue afforded 
the hydroxy-phosphorane (32) as a white foam [0.24 g, 16% from hemiaminal 
(22)]
Vmax (CHC13) 3610, 3400 (b), 1740 (shoulder), 1630, 1440, 1240,
1170, and 1110 cm*"^ .
S(CDC13 ) 0.9 (9 H, s, Bl£), and 7.5-7.9 (15 Hi, m, PPh3 )
(Found: R+ , 519.21784. requires N, 519.21744).
Attempted Oxidation-Intramolecular Uittig Condensation of Hydroxy-
Phosphorane (32)
The hydroxy-phosphorane (32) (100 mg, 0.2 mmol), was dissolved 
in a mixture of DRS0 (2 ml) and acetic anhydride (2 ml). The solution 
was stirred, under an atmosphere of argon, for 16 h when tic monitoring
O
indicated complete oxidation. The mixture was heated at 50 C for 2 h, 
concentrated in vacuo, the residue dissolved in ethyl acetate, washed 
with water, dried and evaporated iin vacuo. Preparative tic (develop­
ing solvent ethyl acetate - light petroleum) afforded only products of 
decomposition.
Imine-Ketene Cycloaddition Approach
-69-
N-(Diethoxyacetyl) piperidine (50)
31
This was prepared by the literature method , and was obtained 
as a colourless oil, bp 120°C at 1 mmHg (lit. bp 87-90°C at 0.12-0.15 
mmHg).
5(CDC13 ) 1.12 (6 H, t, 3 6 Hz, 2 x 0CH2CH3), 1.55 (6 H, m,
-{•CH2 f  ), 3.60 (8 H, m, 2 x 0CH2CH3 and CH2NCH2), 
and 4.95 (1 H, s, CH)
l,l-Diethoxypent-4-en-2-one (51)
31
This was prepared by an extension of a published procedure.
* 50 r
To a stirred solution of allyl magnesium chloride [from magnesium
(24.3 g, 1 mol) and allyl chloride (27.4 g, 0.36 mol)j in ether (400 ml) 
was added the piperidine (50) (31 g, 0.14 mol), dropwise, with stirr­
ing, over 30 min. at 0°C in an atmosphere of nitrogen. The solution 
was heated under reflux, with stirring, under nitrogen, for 16 h.
O
The reaction mixture was cooled to —15 C and poured on to saturated
O
ammonium chloride solution (1 1) at -15 C. The aqueous solution was 
extracted with ether (3 x 500 ml), the ethereal extracts dried over 
anhydrous sodium sulphate, and the solvent removed under reduced press­
ure to give the crude ketone (51).
(CDC13 ) 1.23 (6 H, t, 3 7 Hz, 2 x 0CH2CH3), 3.5 (6 H, m,
2 x 0C(H2CH3 and C0CH2), 4.6 (1 H, s, CH), 5.1 (2 H, 
m, C=CH2), and 5.9 (l H, m, HC=CH2).
Due to its lability towards conjugation,(51) was used immediately in 
the following reaction, without purification.
-70-
1.1—Diethoxy-2-hydroxypent-4-ene (53)
The crude ketone (51), from above,was dissolved in ethanol 
(100 ml, 95%) and added rapidly to a stirred solution of sodium boro- 
hydride (60 g, 1.5 mol) in water (225 ml) and ethanol (50 ml, 95%) at 
0°C. The solution was allowed to warm up to room temperature, with 
stirring, over a period of 3 h. The reaction mixture was poured on 
to water (400 ml) and extracted with ether (3 x 400 ml). The combined 
ethereal extracts were dried and concentrated under reduced pressure* 
Distillation afforded the alcohol (53) as a colourless liquid [l8 g,
725# based on piperidine (50)J bp 80°C at 1.5 mmHg.
Vmax 3450 (broad), 1640, 1440, 1370, 1280, and 1110 cm
S(C0C13) 1.2 (6 H, t, 3 7 Hz, 2 x 0CH2CH3), 2.3 (l H, bs,
exchanges with D20, OH), 3.6 (7 H,: m, 2 X OCH^O^ and 
CH2CH0H), 4*.3(1 H, d, 3 2 Hz,' CH^OEt)2_), 5*1 (2 H, m,
C=CH2), and 5.8 (l H, m, CH=CH2).
(Found: C, 62.2, H, 10.2. c5H1a°3 reclu^res 62.05, H, 10.4%).
1.1-Diethoxy—2-benzyloxypent-4-ene (54)
To a slurry of sodium hydride (1.82 g, 1G05», 80 mmol) in THF 
(50 ml) under an atmosphere of argon was added alcohol (53) (12 g,
70 mmol) dropwise with stirring over 30 min. at room temperature. The 
reaction mixture was stirred and heated under reflux for 2 h., then 
cooled to 0°C when benzyl bromide (12.4 g, 75 mmol) was added dropwise, 
with stirring, over 30 min. The reaction mixture was heated under 
reflux for 2 h., cooled, and stirred for 16 h. Ethanol was added 
dropwise to quench excess sodium hydride, and the solution poured on to
—7L
water (100 ml). The aqueous solution was extracted with ether 
(3 x 150 ml), and the combined ethereal extracts washed with brine, 
dried, and concentrated i n  vacuo. Distillation of the residue afforded 
the benzyl ether (54) as a colourless liquid (13.5 g, 74%), bp 94°C at 
0.15 mmHg.
"i/max 1650, 1440, 1360, 1060, 905, 725 and 690 cm”1.
cT(CDC13) 1.23 (6 H, t, 3 8 Hz, 2 x 2.4 (2 H, m,
CH2CH=CH-2), 3.6 (5 H, m, 2 x 0CH. CH3 and CHOQ^Ph),
4.4 (1 H, d, 3 6 Hz, CH(QEt) ), 4.7 (2 H, s, CH2Ph),
4.9-5.3 (2 H, m, C=CH2), 5.6-6.2 (1 H, m, CH=CH2), 
and 7.3 (5 H, m, Ph).
(Found: C,72.75, H, 9.05. ^ 6^24^3 requires C, 72.70, H, 9.15%).
2-Benzyloxypent-4-enal (35)
A solution of 1,l-diethoxy-2-benzyloxypent-4-ene (54) (4 g, 15 mmol) 
and jg—toluenesulphonic acid monohydrate (400 mg, 2 mmol) in acetone 
(AnalaR, 40 ml) and water (4 ml) was heated under reflux for 3.5 h.
The solution was cooled and concentrated iri vacuo, salt was added to 
the aqueous residue which was then extracted with ether (3 x 40 ml).
The combined ethereal extracts were washed successively with saturated 
sodium bicarbonate and brine, dried, and the solvent removed under 
reduced pressure. Distillation of the residue afforded the aldehyde
(35) as a fragrant colourless liquid (2.1 g, 73%) bp 80 C at 0o25 mmHg.
\fmax 2705, 1740, 1650, 1455, 1060, 1045, 915, 740, and
700 cm”1.
§"(CPC13 ) 2.5 (2 H, m, CH^CH^), 3.84 (l H, dt, 3 6 Hz and
3 2 Hz, CHCC_H2Ph), 4.64 (2 H, s, CH^Ph), 5.1 (2 H,
-72-
m, CH=CH2), 5.9 (1 H, m, CH=CH2), and 7.4 (5 H, s, Ph).
(Found: m/e, 161. (M-CHO) requires 161).
Azidoacetic Acid
This was prepared by the literature^1 method, and was obtained
as a colourless oil which, due to its instability, was used without
further purification.
Vmax 3000 (broad), 2100, 1725, 1420, 1380, and 1215 cm 1.
Azidoacetyl Chloride
52This was prepared by the published procedure and was obtained
0 , 0  
as a mobile colourless oil, bp 62—63 C at 25 mmHg (lit. bp 55—60 at
18 mmHg).
Vmax 2100, 1800, 1740, 1410, 1270, 1200, 905, and 760 cm”1.
Preparation of theyg-Lactams (55) and (56)
A solution of 2—benzyloxypent—4-enal (35) (2.5 g, 13 mmol) and 
2,4—dimethoxybenzylamine (2.2 g, 13 mmol) in ether (60 ml) was stirred 
in the presence of anhydrous magnesium sulphate for 2 h at room temper­
ature. The mixture was filtered, concentrated in vacuo, and then 
dissolved in THF (60 ml) under an atmosphere of argon. Triethylamine 
(1.98 g, 19.6 mmol) was added and the solution was cooled to —78 C. 
Azidoacetyl chloride (2.33 g, 19.5 mmol) was added dropwise to the 
stirred solution. The cooling bath was removed and the mixture allowed 
to come to room temperature, stirred for 10 h, filtered, and concen­
trated in vacuo. Column chromatography (eluting solvent ethyl acetate—
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light petroleum) of the crude reaction product afforded pure cis- j3  — 
lactam (55) as a colourless oil (2.84 g, 51?b)
Vmax 2100, 1760, 1610, 1590 and 1505 cm"1.
c>(CDC13 ) 2.35 (2 H, b m, CH2CH=CH2), 3.55 (l H, m, CHNCD),
3.64 (3 H, s, CH30), 3.72 (3 H, s, CH30), 4.07 and
4.64 (2 H, ABq, 3 14.5 Hz, CH2 Ar), 4.35 and 4.64
(2 H, ABq, 3 11 Hz, CH.2 Ar), 4.1-4.4 (1 H, b m,
CH0CH2Ph), 4.50 (1 H, d, 3 5 Hz, CHN3), 5.05 (2 H;,
b m, CH=CH2), 5.75 (1 H, b m, CH=CH2), 6.30 and 6.86 
(3 H, m, Ar.), 7,25 (5 H, s, Ph)
(Found: M*, 422. *-23^26°4W4 rePu^res 422). and a mixture of cis-
j5 -lactam (55) and trans-lactam (56) as a cloudy oil (1.05 g, 19JS)
§(CDC1_) 4.5 (1 H, d, ] 5 Hz, CHNj cis and 4.5 (1 H, d, 0 2
Hz, CHNg trans).
Preparation of the Phenoxyacetamido -Lactam (57)
A stream of hydrogen sulphide gas was bubbled through a solution
of azido-y0- lactam (55) (475 mg, 1.13 mmol) and triethylamine (570 mg,
5.65 mmol) in methylene chloride (50 ml) at 0°C for 30 min. The solut­
ion was stirred for 1 h at room temperature, concentrated i n  vacuo, 
and the crude amine redissolved in methylene chloride (10 ml). Triethy­
lamine (193 mg, 1.91 mmol) was introduced into the solution and phenoxy-
O
acetyl chloride (232 rng, 1.36 mmol) added dropuise with stirring at 0 C.
The mixture was stirred for 1 h at room temperature, washed with water,
dried, and concentrated in vacuo. Column chromatography (eluting 
solvent ethyl acetate - light petroleum) afforded phenoxyacetamido-- 
lactam (57) as a gum [ 180 mg, 30£ from azido-y#-lactam (55) J which
-74-
crystallised from benzene - light petroleum, or ether, to give fine
o
white crystals, mp 130-135 C
~s)max 3410, 1750, 1690, 1620, 1600, and 1590 cnT1.
S(CDC13) 2.3 (2 H, ABq, 3 6 Hz, CH2CH=CH2), 3.78 (3 H, s, 0CH3 ),
3.80 (3 H, s, 0CH3), 4.47 (2 H, s, CH20Ph), 7.29 (5 H,
s, Ph), 3.3-5.8 (10 H, m, CHCHM^NCH^CHXOCH^h)CH2CH=
CH2), 6.3-7.0 (9 H, m, Ar and NH)
(Found: M+ , 530.24158. .0-No requires M, 530.24167).
oj. 34 u 2
Attempted N-Deprotedtion of f t -Lactam (57)
The ^-lactam (57) (250 mg, 0.5 mmol) was dissolved in 40% aqueous
acetonitrile (30 ml) and the solution flushed with argon. Potassium
persulphate (K_So0o) (510 mg, 2 mmol) and disodium hydrogen orthophos- 
2 2 □
phate (Na2HP0^) (134 mg, 1 mmol) were added and the mixture was heated 
under reflux, in an atmosphere of argon, for 45 min. Volatiles were 
removed under reduced pressure, and the residue extracted with ethyl 
acetate. The combined ethyl acetate extracts were dried and concentr­
ated in vacuo to give a dark viscous oil (210 mg). Preparative tic 
(eluting solvent ethyl acetate - light petroleum) gave 2,4-dimethoxy-
O o
benzaldehyde (59), mp 70-71 C (lit. mp 71 0), and a mixture of polar 
compounds which were not yS-lactams, as evidenced by their lack of 
absorption in the region 1800-1700 cm  ^in the infra-red spectrum. 
Variations of the reaction temperature and time, and the addition of 
silver nitrate did not alter the outcome of this reaction. Attempted 
deprotection using TFA also failed.
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Diethyl Aminomethylphosphonate (63)
36This was prepared by the method of Regitz , and was obtained asL
a yellow oil which, due to its extreme lability, was used immediately
without purification.
S(CDC13 ) 1.36 (6 H, t, 3 7 Hz, 2 x 2.3 (2 H, bs,
exchanges with DO, NH_), 3.0 (2 H, d, 3 11 Hr,
2 2 H— r
CH2NH2 ), and 4.3 (4 H, d q, 3H_H 7 Hz, dH_p 8 Hz,
2 x OCH. CH,).
Benzaldehyde Imine of Diethyl Aminomethylphosphonate (64)
A solution of benzaldehyde (14.5 g, 0.14 mol) in toluene (200 ml) 
was added to a solution of diethyl aminomethylphosphonate (64) (23 g, 
0.14 mol) in toluene (200 ml) with stirring at 0°C. The reaction 
mixture was stirred for 1 h at room temperature and concentrated in 
vacuo with final azeotroping with toluene to remove the water produced 
in the reaction. Distillation gave the imine (64) as a pale yellow oil 
(20 g, 575*), bp 160°C at 1 mmHg.
S(CDC13 ) 1.35 (6 H, t, 3 7 Hz, 2 x 0CH2CH3), 3.9-4.4 (6 H, m,
2 x 0CH_2CH3 and CH^P), and 7.2-8.4 (6 H, m, Ptn and 
N=CH).
Preparation of the Glycine Derivative (65)
This was prepared by a modification of the published procedure • 
To a solution of isopropylcyclohexylamine (12.7 g, 90 mmol) in THF 
(150 ml) at room temperature, in an atmosphere of argon, was added
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ji-butyl lithium (48 ml, 1.6M in hexane, 90 mmol). The solution was 
cooled to -78 C and a solution of the phosphonato—imine (64) (8 g, 30 
mmol) in THF (10 ml) was added dropwise with stirring. The mixture 
was stirred for 40 min, then a solution of benzyl chloroformate (13.0
g, 90 mmol) in THF (10 ml) was added dropwise. The reaction mixture
o
was stirred for 2 h at —78 C, then allowed to warm slowly to room temp­
erature and poured on to saturated aqueous ammonium chloride solution 
(100 ml). The aqueous solution was extracted with ether, and the com­
bined ethereal extracts washed with brine, dried, and concentrated in 
vacuo. Column chromatography (eluting solvent ethyl acetate - light 
petroleum) of the residue on alumina (Uoelm, Grade V basic) afforded 
the protected glycine derivative (65) as a yellow oil (5 g, 50/b).
Vmax 1730, 1700, 1635, 1440, 1370, 1250, 1140, and 1020 cm"1.
S(CDC13) 1.2-1.7 (6 H, m, 2 x 0CH2CH3 ), 4.0-4.6 (4 H, m, 2 x
0CH2CH3 ), 4.75 (1 H, d, Z)H_p 20 Hz, CHP0), 5.3 (2 H, 
s, CH2Ph), 7.2-8.0 (10 H, m, 2 x Ph), and 8.4 (1 H, 
d, 0 5 Hz, CH=N).
Benzyl(2-Amino—2-diethylphosphonato)acetate (36)
To a solution of the above protected glycine derivative (65) (1.3 
g, 3.34 mmol) in ether (60 ml) was added £-toluene sulphonic acid mono- 
hydrate (1.3 g, 6.8 mmol) and the mixture stirred for 3 h at room temper­
ature, after which time a brown gum had separated. The supernatant 
solution was decanted and the gum triturated with ether and dissolved 
in saturated aqueous dipotassium hydrogen orthophosphate (l^HPO^) solution
40 ml) and extracted with ether. The combined ethereal extracts were
o
dried and concentrated in vacuo below 25 C. Column chromatography
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(eluting solvent ethyl acetate - light petroleum) afforded the amine 
(36) as a labile colourless oil (450 mg, 45%)
This was prepared by an extension of a published procedure. A 
solution of amine (36) (450 mg, 1.5 mmol) and aldehyde (35) (285 mg,
1.5 mmol) in methylene chloride (40 ml) was stirred at room temperature 
for 2 h. Anhydrous magnesium sulphate (600 mg) was added and the mix­
ture stirred for a further 1 h, filtered, concentrated iin vacuo, and 
the residue azeotroped with benzene. The crude imine (37) was dissolved 
in benzene (15 ml) and cyclohexane (15 ml) and triethylamine (0.42 ml,
3 mmol) was introduced under an atmosphere of argon. A solution of 
azidoacetyl chloride (0.26 ml, 3 mmol) in cyclohexane (30 ml) was added 
dropwise with stirring, at room temperature, over a period of 1 h.
The reaction mixture was diluted with benzene and washed successively 
with pH 3 phosphate buffer, water, pH 8 phosphate buffer and brine; 
it was then dried, and concentrated _in vacuo. Column chromatography 
(eluting solvent ethyl acetate - light petroleum) of the residue afforded 
pure /3 -lactam (3T) as a mixture of stereoisomers.
Vmax 3600-3250, 1730, 1440, 1370, and 1240 cm”1.
c>(CDC13 ) 1.35 (6 H, t, 3 7 Hz, 2 x 0CH2CH3 ), 2.1 (2 H, bs,
exchanges with D20, NH2), 3.7-4.3 (5 H, m, 2 x OCH^- 
CH3 and CHP0), 5.2 (2 H, s, 0CH2Ph), and 7.35 (5 H, 
s, Ph).
Preparation of the^-Lactam (39) 
,38
Vmax 2100, 1775, 1740, and 1675 cm 1.
S"(CDC13 ) broad and largely unresolved, peaks at 1.0-1.4 (6
-78-
H, bm, 2 x 0CH2CH3), 3.8-5.3 (12 H, bm), and 7.3 (10 
H, s, 2 x Ph).
(Found: 556.20801. requires 556.20865).
Ozonolysis of f t -Lactam (39) - Preparation of Oesmethyl-carbacephem (71)
A stream of ozone and oxygen was bubbled through a solution of 
-lactam (39) (100 mg, 0.18 mmol) in methanol (AnalaR, 5 ml) at -78°C 
until a faint blue colour persisted. A stream of nitrogen gas was then 
bubbled through the solution for 30 min to purge excess ozone. The 
dry—ice bath was removed and the solution allowed to warm up with stirr- 
ing. When the reaction mixture reached -40 C sodium borohydride (6 mg,
0.16 mmol) was added and the solution then allowed to come to room temp­
erature over 30 min with stirring. Dilute aqueous hydrochloric acid 
(10/^ , 3 drops) was added, and the solution concentrated in vacuo. The 
residue was dissolved in brine which was then extracted with ethyl
acetate. The combined ethyl acetate
extracts were dried, and concentrated under reduced pressure. Prepar­
ative tic (eluting solvent ethyl acetate - light petroleum) of the 
residue afforded desmethyl—carbacephem (71) in low yield as a colourless 
oil, which became a waxy solid after storing at -20°C for several weeks.
>/max 2100, 1780, 1715, and 1630 cm 1.
(Found: m/e, 376.14237. C22H20N2°4 re3uires 376.1423).
Attempts to prepare the aldehyde (70) by reducing the ozonide, 
obtained in this reaction, with dimethyl sulphide, triethylamine, 
triphenylphosphine, or catalytic hydrogenation were unsuccessful.
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2-Benzyloxy—4-methylpent-4-enal (87)
l,l-Diethoxy-2-benzyloxy-4-methylpent-4-ene (86) [ 4 g, 14.4 mmol, 
53
prepared by substituting methallyl chloride for allyl chloride in a 
synthesis otherwise identical to that of the desmethyl analogue (54) J 
was deprotected as described above for liberation of the desmethyl alde­
hyde (35), to give the aldehyde (87) as a fragrant colourless oil (2 g,
68 c^) bp 84°C at 0.6 mmHg
max (CHC13 ) 1730, 1650, 1500, 1460, 1380, and 1110 cm"1.
§  (C0C13) 1.75 (3 H, s, CH3), 2.45 (2 H, d, 3 7 Hz, CH2C=C),
3.95 (1 H, 6 lines, t, 3 7 Hz, further coupled d,
3 2 Hz, CH0CH2Ph), 4.7 (2 H, s, CH^Ph), 4.9 (2 H,
bs, C=CH2), 7.4 (5 H, s, Ph), and 9.7 (1 H, d,
3 2 Hz, CH=0)
(Found: M+ , 204.11459. C..„H,c0o requires M, 204.115023).
l J  l b  4
Preparation of & -Lactam (80)
This was prepared from aldehyde (87) (2.23 g, 10.9 mmol), amine
(36) (3.4 g, 11.3 mmol), and azidoacetyl chloride (2 ml, 23 mmol) by 
the method previously described for the synthesis of the desmethyl y(3- 
lactam (39), and was obtained as a pale yellow oil (4 g, 64^) which was 
a mixture of diastereoisomers.
Vmax 2100, 1780, 1745, and 1650 cm"l
S(CDC13) broad and largely unresolved, peaks at 1.0-1.4
(6 H, bm, 2 x OCH^H^), 1.6-1.9 (3 H, bm, CH3C=C),
3.8-5.3 (12 H, bm), and 7.3 (10 H, bs, 2 x Ph). 
(Found: m/e 542.21839. ^ g H ^ N ^ P  ( M 2) requires 542.21815).
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Preparation of Keto—yg-Lactam (91)
A stream of ozone and oxygen was bubbled through a solution of 
^-lactam (80) (3 g, 5.3 mmol) in methanol (AnalaR, 100 ml) at -78 C
until a faint blue colour persisted. A stream of nitrogen gas was then 
bubbled through the solution for 1 h to purge excess ozone. Dimethyl 
sulphide (20 ml, 270 mmol) was added and the dry-ice bath removed. The 
solution was allowed to warm up to room temperature with stirring for 
4 h. Volatiles were removed under reduced pressure, the residue was 
dissolved in ethyl acetate, washed with brine, dried, and concentrated 
in vacuo. Column chromatography (eluting solvent ethyl acetate — light 
petroleum) of the residue afforded the keto-/3-lactam (81) as a colour­
less oil (2.4 g, 80%) which was a mixture of diastereoisomers as evidenc­
ed by a broad and unresolved nmr spectrum.
\Tmax 2100, 1775, 1745, and 1720 cm
(Found: m/e, 544.1973. C27H33N2°8P (M-N2) requires 544.19742).
This diastereoisomeric mixture of ketones was separable by pre­
parative tic (multiple elution with ethyl acetate - light petroleum) 
into two diastereoisomeric components. 
less polar component (89)
S(CDC13) 1.25 (6 H, t, 3 8 Hz, 2 x 0CH2CH3), 1.26 (6 H, t, 3
8 Hz, 2 x 0CH2qi3), 2.0 (3 H, s, DijCO), 2.22 (3 H, 
s, CH3C0), 7.29 (10 H, s, 2 x Ph) and 7.35 (10 H, s,
2 x Ph). 
more polar component (90)
^(CDC13) 1.1-1.3 (12 H, m, 4 x OCH^H^), 2.11 (3 H, s, CHgCO),
2.15 (3 H, s, CHgCO), and 7.2-7.4 (20 H, m, 4 x Ph).
-81-
Preparation of Carbacephem (88)
To a stirred suspension of sodium hydride (10 mg, 0.42 mmol) in 
□ME (3 ml) at -40 C under an atmosphere of argon was added a solution of 
keto-phosphonate (81) (250 mg, 0.44 mmol) in DME (2 ml). The cooling 
bath was removed and the solution allowed to come to room temperature,
O
with stirring. The mixture was then heated to 50 C for 1 h, cooled
O
to 0 C, and poured on to brine. The aqueous solution was extracted
with ethyl acetate and the combined ethyl acetate extracts were dried
and concentrated iri vacuo. Preparative tic (eluting solvent ethyl
acetate - light petroleum) afforded unreacted keto-phosphonate (80 mg,
32%) identical in all respects with the more polar ketone component (90)
obtained previously, and carbacephem (88) as a colourless oil (80 mg,
44^ b) which on crystallisation from ethyl acetate - light petroleum gave
o
powdery white crystals mp 93.5 - 94 C.
Vmax (CHC13 ) 
c> (CDC13 )
Xmax (CH30H)
2110, 1775, 1720, and 1545 cnT1.
2.0 (3 H, s, CH3C=C), 2.15 (l H, four lines, d,
18.5 Hz, further coupled, d, 3^  8.5 Hz, H^),
2.65 (1 H, four lines, d, 3dg 18.5 Hz, further 
coupled, d, 3 6 Hz, H ), 3.63 (1 H, four lines,
C6 S
d, 3^c 8.5 Hz, further coupled, d, 3ab 4.5 Hz, H^),
3.9 (1 H, six lines, d, 3fac 8.5 Hz, further
coupled, d, 3cd 8.5 Hz, further coupled, d, 3cg 6
Hz, H ), 4.63 (2 H, s, CHOCH.Ph), 4.9 (1 H, d, 3 , c ao
4.5 Hz, H ), 5.21 (2 H, s, CO^H^h), and 7.3 (10 
H, s, 2 x Ph)
265 nm.(£, 9550. )
(Found: C, 66.23; H, 5.07; N, 13.2. *-23^22^4^4 rec u^^res 66.03;
H, 5.26; and N, 13.4^).
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Preparation of Carbacephem (91)
This was prepared from the unreacted keto-phosphonate (90) (334 mg, 
0*58 mmol) by the method described above for the production of the diast— 
ereoisomeric compound (88), with the exception that the mixture was • 
heated under reflux instead of at 50°C. The resulting carbacephem (91) 
was obtained (110 mg, 45%) as a white crystalline solid mp 104—106 C.
Vmax (CHC13) 2110, 1775, 1720, and 1645 cm-1.
S(CDC1,) 1.92 (3 H, s, CH„C=C), 2.3 (2 H, eight lines, AB ,
j o q
3 18.5 Hz, further coupled, d, 3 2.5 Hz, CH2C=C),
3.6 (1 H, four lines, d, 3Qb 5 Hz, further coupled, 
d, 3, 1.5 Hz, H. ), 4.07 (l H, four lines, d, 3
DC O OO
2.5 Hz, further coupled, d, 3cd 2.5 Hz, further
coupled, d, 3fac 1.5 Hz, H ), 4.65 (1 H, d, 3Qb 5
Hz, Ha ), 4.7 (2 H, ABq, 3 12 Hz, CHOCH^Ph), 5.27
(2 H, s, C02CH2Ph), and 7.2-7.5 (1C- H, m, 2 x Ph).
(Found: C, 66.32; H, 5.50; N,13.33. C23H22^404 r0clu:i-res c» 66.03;
H, 5.26; and N, 13.40%).
Preparation of the Phenoxyacetamido—carbacephem (93)
A stream of hydrogen sulphide gas was bubbled through a solution 
of azido—carbacephem (88) (100 mg, 0.24 mmol) and triethylamine (121 mg,
I.2 mmol) in. methylene chloride (10 ml) at 0 C for 30 min. The cooling 
bath was removed and the solution stirred for 1 h at room temperature 
then evaporated to dryness in vacuo. The crude amine (92) was redissol— 
ved in methylene chloride (5 ml) and triethylamine (48 mg, 0.48 mmol) 
introduced in to the solution. Phenoxyacetyl chloride (61 mg, 0.36 mmol)
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was added dropwise with stirring at 0 C* The cooling bath was removed 
and the reaction mixture stirred for 1 h at room temperature. The 
solution was diluted with methylene chloride (15 ml) and washed success­
ively with dilute hydrochloric acid (10%), water, and brine, then 
dried and concentrated jm vacuo. Preparative tic (eluting solvent ethyl 
acetate - light petroleum) of the residue afforded phenoxyacetamido- 
carbacephem (93) as an oil which crystallised from ethyl acetate - light 
petroleum to give white crystals (94 mg, 75/;) mp 153-154 C.
Vmax (CHC13 ) 3400, 1770, 1720, 1690, 1640, 1600, and 1590 cm""1.
S(CDC13 ) 3.7-4.0 (2 H, bm, CHOCH^h and CJdN), 4.5 (2 H,
AB , 3 11 Hz, 0CHoC0), 5.6 (l H, four lines, d, 
q —2
3 4.5 Hz, further coupled, d, 3 9 Hz, NHCHCO),
6.8-7.5 (15 H, m, 3 x Ph), 7.93 (1 H, d, 3 9 Hz,
NH), and other signals as for carbacephem (88). 
Xmax (CH30H) 265 nm.(£, 14530.)
(Found: C, 70.74; H, 5.9; N, 5.25. C3^H3q05N2 reciu:i-res 70.72;
H, 5.7; and N, 5.32%).
Preparation of the Carbacephalosporanic Acid (95)
«
To a solution of the-protected carbacephem (93) (100 mg, 0.19 mmol) 
in ethyl acetate (30 ml) was added 10% Pd/C catalyst (50 mg). The mix­
ture was agitated under an atmosphere of hydrogen (45 psi) for 1 h, filt­
ered, and the filtrate partitionea between ethyl acetate and saturated 
aqueous sodium bicarbonate. The separated aqueous layer was acidified 
with dilute hydrochloric acid and extracted with ethyl acetate. The 
combined ethyl acetate extracts were dried and concentrated in vacuo to 
give the crude carbacephalosporanic acid (95) as an oil which crystallised 
from acetone - light petroleum to give white crystals (43 mg, 52%) mp
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206-208 C.
V"max (KBr disc)
cT (dg-DHSO)
Xmax (CH^OH)
3300, 1775, 1720, 1690, 1675, 1640, 1600, 
and 1590 cm ■*■.
3,7 (l H, four lines, d, 3 4,5 Hz, further 
coupled, d, 3 8,5 Hz, CHN), 4,2 (l H, bm, CHO- 
CH2Ph), 4.5 (2 H, ABq, 3 11 Hz,- OCH^O), 4.52 
(2 H, s, CHOCH^Ph), 5.5 (l H, four lines d, 3
4.5 Hz, further coupled, d, 3 9 Hz, NH CHCQ), 
7.25 (5 H, s,_CH0CH2Ph), 6.9-7.4 (5 H, m, PhD),
9.03 (1 H, d, 3 9 Hz, NH) and other signals as 
for carbacephem (88).
263 nm.(6, 9870 . )
(Found: C, 66.32; H, 5.76; N, 6.25. C24H24°6N2 re9uires c» 66.06;
H, 5.50; and N, 6.42^)»
The addition of TFA to the reaction mixture did not alter the 
course of the reaction. In another attempt to remove both benzyl ester 
and ether simultaneously, using trimethylsilyl iodide in CDCl^, only 
decomposition of starting material was observed.
Preparation of Phenoxyacetamido—carbacephem (96)
The azido-carbacephem (91) (100 mg, 0.19 mmol) was reduced and acy- 
lated as described above, for the preparation of the diastereoisomeric 
amide (93), to give the phenoxyacetamide (95) as a white crystalline 
solid (50 mg, 40?i) mp 137-138° C.
Vmax (K3r disc) 3420, 1765, 1720, 1690, 1635, 1600, and 1590 cnf1
4.47 (2 H, s, CH0CH2Ph), 4.50 (2 H, s, OCH^O), 
5.82 (1 H, four lines, d, 3 10 Hz, further
c>(cdci3)
■85-
coupled, d, 3 5 Hz, NHCHCO), 6.4-7.5 (15 H, 
m, 3 x Ph), 7.7 (1 H, d, 3 10 Hz, NH), and other 
signals as for carbacephem (91).
Xmax (CH30H) 267 nm.(£, 8730.)
(Founds C, 70.5; H, 5.68; N, 5.47. C31h3q°6N2 re9uires c* 70-72;
H, 5.7; and N, 5.32%).
Preparation, of Carbacephalosporanic Acid (97)
The protected carbacephem (96) (80 mg, 0.15 mmol) was deprotected 
as described above for the diastereoisomeric compound (95), to give the 
carbacephalosporanic acid (97) as a white crystalline solid (9 mg, 14%) 
mp 182—185°C.
S  (dc-DMS0) 3.95 (1 H, d, 3 5 Hz, CHN), 4.6 (2 H, s, 0CHoC0), 
b Z.
5.64 (1 H, four lines, d, 3 5 Hz, further coupled, 
d, 3 10 Hz, NH CHC0), 7.3 (5 H, s, CH0CH2_Ph), 6.5-
7.4 (5 H, m, PhO), 7.67 (1 H, d, 3 10 Hz, NH), 12.9 
(1 H, bs, CO^H), and other signals as for carbacep— 
hem (91).
(Found: m/e, 392.17381. C23H24N2°4 (PO—C02) requires 392.173596).
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